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1 SUMMARY 
1.1 English Summary 
In the last decade, the application of genetically-encoded biosensors proved successful to 
establish novel and elaborated strategies for engineering microbial cell factories by enlarging the 
repertoire of metabolic engineering tools and by enabling unprecedented insights into 
bioprocesses at single-cell resolution. Especially, biosensors based on bacterial transcriptional 
regulators translating intracellular metabolite concentration into a measureable output proved to 
be of high value for a variety of metabolic engineering approaches. 
Although nature provides a plethora of transcriptional regulators to sense intrinsic and 
extrinsic stimuli, only a few regulators and their respective target promoters have been well 
characterized to date. This hampers the prompt decision for suitable sensor candidates. To this 
end, an elaborated FACS (fluorescence-activated cell sorting)-based strategy was developed for 
the rapid identification of effector-responsive promoters as suitable parts for biosensor design. 
Basically, a library of Escherichia coli promoter-auto-fluorescent protein fusions was screened 
by toggled rounds of positive and negative selection. This approach led to the isolation of the L-
phenylalanine-responsive mtr promoter. The construction of different biosensors based on the mtr 
promoter revealed a significant influence of the sensor’s architecture on the dynamic range and 
the sensitivity towards effector molecules. Additionally, the mtr biosensor was successfully 
applied to screen a mutant library of E. coli cells for cells with increased L-phenylalanine 
productivity.  
Adaptive laboratory evolution (ALE) has widely been applied to adapt microbes to 
environmental stress or to improve metabolite production. So far, however, the strategy was only 
applicable to fitness-linked phenotypes. To this end, we established biosensor-driven adaptive 
laboratory evolution to evolve inconspicuous product formation. Sensor cells with the highest 
fluorescent output and hence, increased metabolite production, were iteratively isolated by FACS 
and re-cultivated. This strategy was successfully applied to the pyruvate-dehydrogenase deficient 
L-valine producer strain Corynebacterium glutamicum ΔaceE using the Lrp biosensor, which was 
developed for the detection of branched-chain amino acids and methionine. Evolved clones 
featured about 25% increased production and 3-4-fold reduced by-product formation. By genome 
sequencing and the subsequent evaluation of single mutations in the cured ΔaceE background, 
decreased L-alanine production was attributed to a mutation in the global regulator GlxR. 
Interestingly, a loss-of-function mutation in the urease accessory protein UreD resulted in about 
100% increased L-valine formation in CGXII minimal medium. Further studies demonstrated 
that urea as part of the cultivation medium imposes a central bottleneck for efficient L-valine 
production: Urea degradation increases the pH by ammonia release, thereby interfering with 
growth and L-valine production. Likewise, carbon dioxide formation stimulates anaplerosis 
leading to a reduced pyruvate pool – the precursor for L-valine production.  
Altogether, these studies emphasize biosensors as valuable and versatile tools to improve 
metabolic cell factories with an enormous potential for future applications.  
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1.2 German Summary 
Im letzten Jahrzehnt hat sich die Anwendung genetisch-kodierter Sensoren als erfolgreich erwiesen, um 
neue und effiziente Strategien für die Entwicklung mikrobieller Zellfabriken zu etablieren. Biosensoren 
vergrößern zum einen das Repertoire an Werkzeugen für die Stammentwicklung und ermöglichen zum 
anderen neuartige Einblicke in Bioprozesse auf Einzelzellebene. Vor allem Biosensoren, die auf 
bakteriellen Transkriptionsregulatoren basieren und so die intrazelluläre Metabolitkonzentration in ein 
messbares Signal übersetzen, spielen aufgrund ihrer vielseitigen Einsatzmöglichkeiten eine große Rolle im 
Metabolic Engineering Bereich.  
Obwohl die Natur eine große Anzahl an Transkriptionsregulatoren hervorgebracht hat, damit Zellen 
intrinsische und extrinsische Signale wahrzunehmen können, gibt es bis heute nur wenige gut untersuchte 
Regulatoren und entsprechende Zielpromotoren. Dies beeinträchtigt allerdings eine schnelle 
Identifizierung neuer Sensorkandidaten. Zu diesem Zweck wurde eine Methode entwickelt, welche auf der 
Fluoreszenz-aktivierten Zellsortierung (FACS) basiert und deren Ziel es ist, schnell neue Promotoren, die 
durch bestimmte Effektoren aktiviert werden, zu identifizieren, um somit neue und geeignete Bausteine 
für die Sensorentwicklung zu gewinnen. Das Grundprinzip besteht darin aus einer Escherichia coli 
Promoter-Sammlung (Promotoren fusioniert an ein autofluoreszierendes Protein) diejenigen Promotoren 
durch abwechselnde Runden positiver und negativer Selektion anzureichern, die durch Effektoren 
aktiviert werden können. Dieser Ansatz führte zur Isolierung des mtr Promoters, der durch Phenylalanin 
aktiviert wird. Die Evaluierung unterschiedlicher mtr-basierter Biosensoren ergab, dass die 
Sensorarchitektur einen signifikanten Einfluss auf den dynamischen Bereich und die Effektormolekül-
Sensitivität hat. Zudem wurden mit Hilfe des mtr Biosensors erfolgreich Zellen mit erhöhter 
intrazellulärer Phenylalaninkonzentration mittels FACS aus eine E. coli Mutantenbibliothek isoliert.  
Im Labor durchgeführte adaptive Evolutionsstrategien werden vielseitig angewendet, um Mikroben 
an Umweltstress anzupassen oder um deren Produktion zu verbessern. Bisher war diese Strategie jedoch 
nur für phänotypische Merkmale geeignet, die direkt an die Fitness des Organismus gekoppelt sind. 
Deshalb haben wir eine Sensor-gesteuerte adaptive Evolutionsmethode entwickelt, um die Produktion 
unscheinbarer Metabolite zu verbessern. Sensorzellen mit dem höchsten Fluoreszenzsignal, was 
gleichzeitig auf eine erhöhte Metabolit-Produktion hindeutet, wurden mehrmals mittels FACS isoliert und 
kultiviert. Diese Methode wurde erfolgreich am Beispiel des Pyruvat-Dehydrogenase-Komplex-
defizienten Valin-Produktionsstammes Corynebacterium glutamicum ΔaceE etabliert. Hier wurde der Lrp 
Biosensor verwendet, der für die Detektion von verzweigtkettigen Aminosäuren und Methionine 
entwickelt wurde. Evolvierte Klone zeigten eine um 25% erhöhte Valin-Produktion und gleichzeitige eine 
drei- bis vierfach reduzierte Nebenproduktbildung. Durch Genomsequenzierung und anschließender 
Evaluierung von einzelnen Mutationen im nicht-evolvierten ΔaceE Stamm wurde gezeigt, dass eine 
Mutation im globalen Regulator GlxR zu einer verringerten Alanin-Produktion führt. Interessanterweise 
führte der mutationsbedingte Funktionsverlust des Urease akzessorischen Proteins UreD bei Kultivierung 
im CGXII Minimalmedium zu einer um 100% erhöhten Valin-Bildung. Weitere Experimente zeigten, 
dass Harnstoff als Bestandteil des Mediums ein zentrales Problem für eine effiziente Valin-Produktion 
darstellt: Durch den Abbau von Harnstoff zu Ammonium steigt der pH-Wert, was das Wachstum positiv, 
aber die Produktion negativ beeinflusst. Ebenso zeigte sich, dass die Bildung von Kohlenstoffdioxid die 
Anaplerose stimuliert, was zu einer reduzierten Pyruvat-Konzentration als Vorstufe der Valin-Biosynthese 
führt.  
Zusammenfassend haben die durchgeführten Experimente gezeigt, dass die Produktion von 
Zellfabriken durch den geschickten und vielseitigen Einsatz von Biosensoren verbessert werden kann. 
Darüber hinaus bieten Sensoren ein enormes Potential für zukünftige Anwendungen. 
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2 INTRODUCTION 
2.1 Microbial cell factories – towards a sustainable bioeconomy 
Since Neolithic times, humans have used microbial fermentation for feed and food refinement 
(Erickson et al., 2012). The awareness of limited fossil resources, untamable industrial waste 
streams and the climate change are currently driving the efforts for the establishment of a 
sustainable bioeconomy. Engineering of microorganisms for the production of value-added 
compounds from renewable feedstocks is one key for the transition from a currently petroleum-
dependent and energy-intensive chemical industry towards a sustainable bioeconomy (Becker 
and Wittmann, 2015; Erickson et al., 2012; Wieschalka et al., 2013). In the last decades, 
microbial processes have been established to build chemical units for the production of a broad 
range of products including solvents, polymers, nutrients, biofuels, bioenergy, flavors and 
pharmaceuticals (Becker and Wittmann, 2015; Woolston et al., 2013). Especially, the market for 
animal feed products has enormously increased. For 2020, the World Economic Forum expects a 
market size of about US$95 billion for products generated by microbial fermentation (Erickson et 
al., 2012).  
Nature has equipped organisms with a plethora of pathways, metabolic reactions and enzymes to 
catalyze the transition of basic carbon sources to complex, high valuable molecules. Superior to 
chemical synthesis, microbial biosynthesis benefits here from chemo-, stereo- and 
regioselectivity of enzymatic reactions, which reduces energy and costs for the intensive 
purification of the desired, enantiopure products (Becker and Wittmann, 2015; Erickson et al., 
2012). Escherichia coli (Chen et al., 2013; Wendisch et al., 2006), Corynebacterium glutamicum 
(Eggeling and Bott, 2015; Heider and Wendisch, 2015; Wieschalka et al., 2013) and 
Saccharomyces cerevisiae (Liu et al., 2013; Nielsen et al., 2013) are traditionally the most 
important workhorses. The deep knowledge of their physiology, aerobic as well as anaerobic 
growth, the availability of a variety of molecular tools and their broad range of metabolic 
products are of great benefit for metabolic engineering purposes (Becker and Wittmann, 2015; 
Woo and Park, 2014).  
In the last decade, next generation sequencing (NGS) techniques, which deliver the detailed 
knowledge of the genetic code in short time and allow in turn for the precise manipulation of the 
genome, revolutionized the field of metabolic engineering. The combination of recombinant 
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DNA technologies, systems and synthetic engineering approaches contributed to this success e.g. 
by allowing for the establishment and transfer of artificial or heterologous pathways in 
production hosts. A broad range of metabolic engineering techniques will be discussed in chapter 
2.3 (“Metabolic engineering of microbial cell factories”). The developments of the last decades 
have pushed the transition from an energy-intensive and fossil oil-dependent chemical industry to 
a sustainable bioeconomy based on renewable resources. Now, the challenge is to engineer 
efficient microbial cell factories, which are economically competitive to traditional production 
processes (Becker and Wittmann, 2015; Erickson et al., 2012).  
2.2 Amino acid production using microorganisms 
Amino acids represent essential building blocks for the synthesis of proteins and diverse 
metabolic intermediates (Mitsuhashi, 2014). For commercial applications, the biotechnological 
production of amino acids nowadays superseded the extraction from protein hydrolysates, which 
was not efficient enough for large-scale production (Leuchtenberger et al., 2005). In addition, 
microbial amino acid biosynthesis provides the great advantage of forming the bioactive L-
enantiomer (except for the non-chiral glycine and methionine) in contrast to chemical synthesis 
(Becker and Wittmann, 2012; Bolten et al., 2010). The global amino acid market faces currently 
an annual microbial production volume of more than 5,000,000 tons (Eggeling and Bott, 2015; 
Wendisch, 2014). The main drivers are L-glutamate and the animal feed additives L-lysine, L-
threonine, L-phenylalanine and D-/L-methionine expecting a market size of US$20.4 billion by 
2020 (Global Industry Analysts Inc, 2015). Due to the lack of the respective biosynthesis 
pathways in humans and animals, all nine essential amino acids (L-histidine, L-isoleucine, L-
leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan and L-valine) are of 
high interest for the establishment of microbial production processes (Becker and Wittmann, 
2012; Leuchtenberger et al., 2005).  
C. glutamicum and E. coli are the main platform organisms for the production of amino acids 
(Becker and Wittmann, 2012; Becker and Wittmann, 2015; Eggeling and Bott, 2015; 
Leuchtenberger et al., 2005; Mitsuhashi, 2014; Wendisch, 2014). However, both organisms 
reveal pros and cons for the production of specific amino acids: Although E. coli features a 
higher theoretical yield for methionine biosynthesis, for example, C. glutamicum uses a less 
complex regulatory control for the production of the same amino acid (Krömer et al., 2006; 
Mitsuhashi, 2014; Tosaka and Takanami, 1986). Furthermore, C. glutamicum can utilize several 
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carbon sources at the same time, while E. coli features sequential carbon utilization leading to 
diauxic growth phenotypes (Wendisch, 2014). In the following, recent efforts for microbial L-
phenylalanine production by E. coli and L-valine production by C. glutamicum are presented in 
more detail.  
Table 2.2: Selected C. glutamicum and E. coli strains engineered for L-phenylalanine or L-valine 
production.  
Strains Genotype Titer 
(g L-1) 
Comments References 
L-phenylalanine     
E. coli Not indicated in detail 50.0 Fed batch fermentation 
on glucose 
(Backman et 
al., 1990) 
E. coli 
F-4/pF81 
LJ110 Δ(pheA tyrA aroF), 
pJF119EH aroFwt pheAfbr 
aroBwt aroLwt  
38.0 50 g L
-1
 during in situ 
product recovery (ISPR) 
(Rüffer et al., 
2004) 
C. glutamicum 
KY10865, pKY1 (aroIIfbr, 
csm
fbr), pKF1 (aroIIfbr, csmfbr, 
pheAfbr) 
28.0 Jar fermentation on 
sucrose  
(Ikeda and 
Katsumata, 
1992) 
E. coli FUS4.11kan 
W3110 Δ(pheA tyrA aroF), 
ΔlacIZYA::Ptac- aroFBL, 
pykA::FRT, pykF::FRT-Kan-
FRT 
13.4 
Fed batch fermentation 
on glycerol and 
ammonia 
(Weiner et al., 
2014a) 
L-valine   
  
C. glutamicum ATCC13032 ΔaceE, pJC4-
ilvBNCE 
22.8 Fed batch fermentation 
on glucose and acetate 
(Blombach et 
al., 2007) 
C. glutamicum ATCC13032 ΔaceE, Δpyc, Δpgi, pJC4-ilvBNCE 48.3 
Fed batch fermentation 
on glucose and acetate 
(Blombach et 
al., 2008) 
C. glutamicum ATCC13032, aceE A16, Δpqo, Δppc, pJC4-ilvBNCE 83.6 
Fed batch fermentation 
on glucose 
(Buchholz et 
al., 2013) 
C. glutamicum 
ATCC13869, ΔaceE, ΔalaT, 
ΔilvA, pJYW-4-ilvBNC1-lrp1-
brnFE 
51.0 Fed batch fermentation 
on glucose  
(Chen et al., 
2015) 
E. coli 
W, ΔlacI, ΔilvA, 
pKBRilvBNmutCED, 
pTrc184ygaZHlrp 
60.7 Fed batch fermentation 
on glucose 
(Park et al., 
2011) 
2.2.1 L-phenylalanine production in Escherichia coli  
Metabolic engineering of L-phenylalanine production in E. coli has been promoted for many 
years reaching final titers of up to 50 g L-1 during growth on glucose (Backman et al., 1990; 
Rüffer et al., 2004) and 13.4 g L-1 during growth on glycerol (Weiner et al., 2014a) (Tab. 2.2).  
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Fig. 2.2.1 Schematic of the biosynthesis of L-phenylalanine by E. coli. The precursors 
phosphoenolpyruvate (PEP) and erythrose-4-phosphate (Ery-4-P) for the general biosynthesis of 
aromatic amino acids are provided directly by glycolysis or via the pentose phosphate pathway 
(PPP). PEP and Ery-4-P are condensed to 3-deoxy-D-arabino-heptulosonate 7-phosphate 
(DAHP) by one of the three DAHP synthases AroF, AroG or AroH, which indicates the start 
point of the shikimate pathway. Via several enzymatic steps, the formation of chorismate is 
catalyzed, which is the shared precursor of all three aromatic amino acids. L-phenylalanine is 
produced from chorismate via prephenic acid catalyzed by prephenate dehydratase. 
Abbreviations: tricarboxylic acid cycle (TCA), 5-enolpyruvoylshikimate 3-phosphate (EPSP). 
Dashed lines indicate the existence of intermediate steps that are not depicted in the figure.  
Besides its important role as precursor for the artificial sweetener aspartame or as building block 
for pharmaceutical products (Sprenger, 2006; Sprenger, 2007), L-phenylalanine became likewise 
interesting as precursor for various aromatic compounds including pinosylvin, cinnamic and p-
hydroxycinnamic acid used as flavor enhancer or ingredients of cosmetics (Sariaslani, 2007; van 
Summeren-Wesenhagen and Marienhagen, 2015; Vargas-Tah et al., 2015). For engineering an 
efficient L-phenylalanine microbial cell factory, E. coli was used as primary workhorse due to its 
rapid growth, the availability of genetic engineering tools and the well-studied biosynthetic 
pathway (Backman et al., 1990; Pittard et al., 2005). Recently, efforts were also taken in C. 
glutamicum to push L-phenylalanine production (Zhang et al., 2014a; Zhang et al., 2015a; Zhang 
et al., 2013). Both organisms produce aromatic amino acids via the shikimate pathway 
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(Fig. 2.2.1), however, with differences in some involved enzymes (Sprenger, 2006). Key targets 
during engineering of E. coli strains for L-phenylalanine production are i) the generation of 
feedback-insensitive versions of the 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) 
synthases AroF, AroG, AroH and chorismate mutase/prephenate dehydratase PheA, ii) the 
improvement of the supply with the precursors phosphoenolpyruvate (PEP) and erythrose-4-
phosphate, and iii) the overproduction of enzymes catalyzing rate limiting steps like the 
shikimate synthase AroL (Bongaerts et al., 2001; Ikeda, 2006; Sprenger, 2007). Although high L-
phenylalanine titers have already been reached during growth on glucose, alternative carbon 
sources are in demand. For example, glycerol as by-product of biodiesel production may reduce 
costs and meets the requirements of a sustainable bioeconomy (Weiner et al., 2014a). The 
negative impact on growth upon high L-phenylalanine concentrations, the delivery of precursors 
or the central metabolism are still bottlenecks, which need to be addressed during engineering of 
production strains (Polen et al., 2005; Weiner et al., 2014b).  
2.2.2 L-valine production in Corynebacterium glutamicum 
The biosynthesis pathway of L-valine branches from the glycolytic product pyruvate (Fig. 2.2.2). 
Hence, the pivotal points for increased L-valine production are the availability of the precursor 
pyruvate and the overproduction of the L-valine biosynthesis pathway, which have been 
addressed during engineering L-valine producer strains (Tab. 2.2). To reach high concentrations 
of pyruvate in C. glutamicum, the deletion of aceE encoding the E1p subunit of the pyruvate 
dehydrogenase complex (PDHC) became a central target to inhibit the degradation of pyruvate to 
acetyl-CoA (Blombach et al., 2007; Schreiner et al., 2005). The drawback of these strains, 
however, is the growth-decoupled production phenotype. Due to the deficiency of PDHC activity, 
acetate has to be added to the medium to maintain the acetyl-CoA level for fueling the 
tricarboxylic acid (TCA) cycle for growth. The presence of acetate, however, abolishes 
phosphoenolpyruvate:sugar phosphotransferase system (PTS)-mediated glucose uptake via the 
regulator sugR required for L-valine production (Blombach et al., 2009; Engels and Wendisch, 
2007). Upon depletion of acetate, L-valine is produced. During fed-batch fermentation, the 
ΔaceE strain produced up to 22.8 g L-1 L-valine (YP/S 0.39 mol L-valine per mol glucose) 
(Blombach et al., 2007). Based on this strain, the deletion of the pyruvate:quinone oxidoreductase 
(Δpqo), which inhibits the degradation of pyruvate to acetate, and the deletion of the 
phosphoglucose isomerase (Δpgi), which pushes carbon flux through the pentose-phosphate  
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pathway (PPP) to enhance the NADPH availability, resulted in final L-valine titers of up to 
48.3 g L-1 (YP/S 0.75 mol L-valine per mol glucose). The additional deletion of the pyruvate 
carboxylase (pyc) preventing the efflux of the precursor pyruvate into the TCA cycle via 
anaplerosis further enhanced YP/S to 0.86 mol L-valine per mol glucose (Blombach et al., 2008; 
Eikmanns and Blombach, 2014). For large-scale industrial production, however, growth-
decoupled and auxotrophic phenotypes as well as the cultivation on two carbon sources are costly 
and laborious. To this end, Buchholz and co-workers reduced the expression of aceE by promoter 
engineering, which allows growth on glucose as single carbon source and resulted in a final L-
valine titer of 83.6 g L-1 (Buchholz et al., 2013). Alternative approaches for increasing L-valine 
production relied on i) the additional deletion of by-product synthesis routes (e.g. L-alanine and 
L-isoleucine), ii) the overexpression of the branched-chain amino acid exporter BrnFE and the 
transcriptional regulator Lrp or iii) on the inactivation of D-pantothenate synthesis to limit CoA 
availability for PDHC activity (Chen et al., 2015; Radmacher et al., 2002). Biomass formation, 
NADPH availability, improved bioprocesses or alternative carbon sources provide certainly 
targets for increasing L-valine production. 
2.3 Metabolic engineering of microbial factories 
Microbes are equipped with a plethora of enzymes and metabolic pathways, which enable the 
conversion of simple carbon sources into highly complex, value-added compounds (Becker and 
Wittmann, 2015). The natural metabolic activity, however, is stringently controlled and reduced 
to a minimal level primarily aiming for proliferation and maintenance. For this reason, the 
Fig. 2.2.2 Schematic of the biosynthesis of 
L-valine in C. glutamicum. The biosynthesis 
pathway branches from pyruvate via 
enzymatic steps catalyzed by acetohydroxy 
acid synthase (AHAS), acetohydroxy acid 
isomeroreductase (AHAIR), dihydroxy acid 
dehydratase (DHAD) and transaminase B 
(TA). Abbreviations: acetate kinase (AK), 
alanine aminotransferase (AlaT and AvtA), 
pyruvate dehydrogenase complex (PDHC), 
pyruvate kinase (PK), phosphoenolpyruvate 
(PEP), pyruvate:quinone oxidoreductase 
(PQO), phosphotransacetylase (PTA). 
Introduction  9 
 
metabolic flux towards product formation is traditionally not maximized to save resources and 
energy. Although microbial refinement of food and drinks unconsciously accompanied mankind 
for several thousands of years, the awareness that living organisms are responsible for e.g. lactic 
acid fermentation discovered by Pasteur in 1857 (Pasteur, 1857), ushered the era of targeted 
microbial applications.  
The first techniques to engineer microbes incorporated the iterative exposition to chemical 
mutagens or ultraviolet (UV) radiation, which generated random mutations throughout the entire 
genome (Benigni et al., 1992; Ghribi et al., 2004; Harper and Lee, 2012; Hughes et al., 2012). 
These mutant libraries were screened for clones with the desired phenotype (Ghribi et al., 2004; 
Ohnishi et al., 2008). Throughout iterative rounds of mutagenesis, however, several thousand 
mutations accumulated in the genome including beneficial, non-profitable and silent mutations. 
Although the resulting strains produced increased amounts of the particular target metabolites, 
the numerous mutations significantly affected the fitness of the cells, which led to slow growth, 
low stress tolerance and decreased robustness during bioprocesses (Becker and Wittmann, 2015).  
During the last two decades, the increasing knowledge of bacterial physiology, the availability of 
sequence data as well as the development of recombinant DNA technologies has enabled the 
targeted deletion and overexpression of endogenous genes as well as the introduction of 
heterologous sequences (Erickson et al., 2012; Heider and Wendisch, 2015; Wendisch, 2014; 
Woolston et al., 2013). This rational design concept realizes the local engineering of metabolic 
pathways with a defined genetic background. Nevertheless, the comprehensive engineering of the 
complex network of metabolic interactions including efficient co-factor and energy supply as 
well as potential metabolic bottlenecks requires a deeper knowledge of the microbial physiology 
(Becker and Wittmann, 2015). Here, systemic analysis provides a novel global and quantitative 
insight into the microbial cell. Comprehensive Omics datasets including valuable quantitative 
information on genes (genomics), transcripts (transcriptomics), proteins (proteomics), metabolites 
(metabolomics) and pathway fluxes (fluxomics) provide a powerful basis for the development of 
mechanisms to control dynamic gene expression, to identify metabolic bottlenecks or to redirect 
metabolic fluxes (Becker and Wittmann, 2015; Furusawa et al., 2013; Petzold et al., 2015; 
Woolston et al., 2013). These strategies allow for the system-wide engineering of microbial cell 
factories. Based on data of multiomic platforms, in silico models can be derived supporting the 
simulation of optimal metabolic fluxes through pathways for high yields – which is, however, 
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still in the early stages of development (Becker and Wittmann, 2015; Kim et al., 2015; Wiechert 
and Noack, 2011).  
Synthetic biology incorporates the full spectrum of genetic engineering possibilities to design cell 
factories with novel features that have never existed before (Church et al., 2014; Way et al., 
2014). Novel synthetic strategies can accelerate the development and commercialization of 
microbial cell factories by overcoming natural barriers such as gene expression noise, metabolic 
by-products, crosstalk or broad enzyme activities (Church et al., 2014; Erickson et al., 2012). To 
this end, a broad range of innovative tools has been developed including CRISPR-Cas9 mediated 
genome editing and multiplex-automated genome engineering (MAGE) of natural and artificial 
genomes (Bonde et al., 2014; Jakociunas et al., 2015; Li et al., 2015; Liu and Jiang, 2015; Ronda 
et al., 2015; Wang et al., 2009), oscillators and genetic switches for the dynamic regulation of 
gene expression cascades (Church et al., 2014; Liu et al., 2015b; Zhang et al., 2012), optogenetic 
tools (Binder et al., 2014; Möglich and Hegemann, 2013), and non-invasive quantification of 
intracellular activities e.g. by biosensors based on native or synthetic transcriptional regulators 
(Chou and Keasling, 2013; Mahr and Frunzke, 2016; Ng et al., 2015; Tang et al., 2008; Woo and 
Park, 2014).  
Although systemic analysis provides a global and comprehensive view of the metabolic 
landscape, the high complexity of carbon and energy fluxes has nowadays not been completely 
understood. There are still many obscured factors including unknown gene activities, regulatory 
mechanisms or detailed knowledge of certain metabolic pathways. During the last years, adaptive 
laboratory evolution approaches driven by mutation and selection have drawn the attention for 
engineering biotechnological interesting strains (Abatemarco et al., 2013; Portnoy et al., 2011; 
Schmidt-Dannert and Arnold, 1999): By iteratively exposing industrial producer strains to 
sequentially increasing levels of environmental stress, microbial strains were adapted to e.g. 
oxidative or thermal stress (Lee et al., 2013; Oide et al., 2015; Sandberg et al., 2014; Tenaillon et 
al., 2012). Further approaches aimed to improve product formation (Mahr et al., 2015; Raman et 
al., 2014; Reyes et al., 2014; Xie et al., 2015) or the tolerance towards solvents (Atsumi et al., 
2010; Lee et al., 2011; Oide et al., 2015). Most strategies are based on the emergence of natural 
mutations and the improvement of fitness-linked phenotypes, which are directly exposed to a 
natural selective pressure. Anyway, an adaptive laboratory evolution approach for inconspicuous 
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product formation not necessary linked to fitness would beneficially expand the toolbox of 
metabolic engineering. 
Another strategy for the comprehensive engineering of microorganisms is the application of 
random genomic mutagenesis, which was reinvigorated by the establishment of efficient 
screening systems based on genetically-encoded biosensors (Delvigne et al., 2015; Dietrich et al., 
2010; Eggeling et al., 2015; Mahr and Frunzke, 2016; Schallmey et al., 2014; Zhang et al., 
2015b). Due to decreasing prices of genome sequencing by NGS, mutations occurring during 
adaptive evolution as well as during biosensor-driven selection of mutant libraries can easily be 
assessed by comparative sequence analysis (Becker and Wittmann, 2015; Harper et al., 2011). 
These strategies revealed to deliver novel, non-intuitive targets for the establishment and 
improvement of industrial production strains.  
2.4 Genetically-encoded biosensors 
Engineering microbes for large-scale production demands efficient tools for the high-throughput 
(HT) development of novel cell factories as well as approaches for the evaluation of the 
bioprocess performance. Techniques for single cell analysis, for instance, are required to discover 
the formation of inefficient subpopulations, which might have a negative impact on the outcome 
and robustness of bioprocesses (Delvigne and Goffin, 2014; Lieder et al., 2014). Moreover, the 
screening of vast strain libraries generated by random or transposon mutagenesis presents a HT 
strategy to identify novel targets for rational engineering approaches. Cases where product 
formation is directly linked to an easily selectable phenotype, e.g. carotenoid production (An et 
al., 1991; Ukibe et al., 2008), or the formation of a chromophore as consequence of an enzyme 
reaction may interface with the development of efficient HT approaches (Santos and 
Stephanopoulos, 2008). However, the majority of biotech-relevant compounds are inconspicuous 
small molecules, which do confer a selectable phenotype to the cell, remains laborious without an 
efficient HT screening tool (Dietrich et al., 2010; Mahr and Frunzke, 2016; Zhang et al., 2015b). 
Here, the development of genetically-encoded biosensors converting the intracellular metabolite 
concentration into a measureable, optical output is of high value for diverse biotechnological 
applications.  
Organisms have evolved a broad repertoire of different mechanisms to sense and respond to 
environmental stimuli including stress, gases, temperature, pH, ions or the availability of 
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nutrients, in order to control gene expression. This spectrum of natural sensor devices comprising 
RNA aptamer structures in riboswitches, transcriptional regulators and enzymes provides a 
valuable repertoire for the construction of biosensors for intracellular metabolite detection.  
 
 
Fig. 2.4 Schematic of biosensors based on A. RNA aptamers, B. FRET and C. transcription 
factors. The biosensors are shown in their OFF (left) and ON state (right) upon binding of 
metabolites (red). Abbreviation: ribosome binding site (RBS), cyan (CFP) and yellow fluorescent 
protein (YFP), Förster (fluorescence) resonance energy transfer (FRET).  
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2.4.1 RNA aptamer-based biosensors 
Riboswitches are non-translated RNA elements, which change their three-dimensional RNA 
aptamer structure upon binding of effector metabolites triggering the efficiency of the gene 
expression machinery, RNA stability or the enzymatic activity of RNA molecules – termed 
ribozymes (Fig. 2.4) (Aboul-Ela et al., 2015; Michener et al., 2012; Serganov and Nudler, 2013). 
The immense power of riboswitch structures regulating gene expression was first described for 
the response to thiamine pyrophosphate (Winkler et al., 2002a), flavin mononucleotide (Winkler 
et al., 2002b) and coenzyme B12 (Nahvi et al., 2002). Nowadays, a wide range of natural 
metabolite-binding RNAs were identified with the help of algorithms e.g. Riboswitch Finder 
(http://riboswitch.bioapps.biozentrum.uni-wuerzburg.de/server.html (Bengert and Dandekar, 
2004)) or Riboswitch Explorer (http://132.248.32.45:8080/cgi-bin/ribex.cgi (Abreu-Goodger and 
Merino, 2005)) and archived in different databases including the Aptamer Base 
(http://aptamerbase.semanticscience.org/ (Cruz-Toledo et al., 2012)). Furthermore, the synthetic 
architecture by computational methods or methods like the SELEX (systematic evolution of 
ligands by exponential enrichment) in vitro assembly technique theoretically allows engineering 
of RNA aptamers for the detection of any desired metabolite (Beisel and Smolke, 2009; Ellington 
and Szostak, 1990). Frequently, the synthetic in vitro or in silico selection of RNA aptamers 
revealed rather low compatibility with in vivo systems (Kopniczky et al., 2015; Liang et al., 2011; 
Schallmey et al., 2014). Alternative approaches rely on the step-wise modification of existing 
RNA aptamers e.g. to alter the specificity (Mannironi et al., 2000). In the last years, RNA 
aptamer-based biosensors have been constructed for visualization of intracellular xanthine (Win 
and Smolke, 2007), for screening a library of mutated caffeine demethylases (Michener and 
Smolke, 2012), as Riboselector for the evolution of L-lysine or L-tryptophan production by the 
fusion of the RNA-aptamer to a selectable marker gene (Jang et al., 2015; Yang et al., 2013), or 
for the control of lysine transport in C. glutamicum (Zhou and Zeng, 2015). Furthermore, Paige 
and co-workers connected metabolite-binding aptamers to fluorophore-binding aptamers for 
sensing S-adenosylmethionine and adenosine 5’-diphosphate (Paige et al., 2012). Recently, this 
type of sensor was shown to be applicable to study metabolite dynamics at the single cell level 
(You et al., 2015). The great advantage of RNA-based biosensors is certainly the save of energy 
and resources as well as the quick response to transient changes during bacterial growth as they 
do not require, for instance, the pre-existence of a transcription regulator (Kopniczky et al., 
2015).  
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2.4.2 FRET-based biosensors 
Another strategy to measure intracellular molecule concentrations is based on Förster 
(fluorescence) resonance energy transfer (FRET) between two auto-fluorescent proteins (AFPs) 
(Fig. 2.4). In principle, the excitation energy of an AFP with short wavelength (FRET donor) can 
be transferred in a radiation-free way to an AFP of high wavelength (FRET acceptor), if both 
AFPs are in close proximity (<10 nm) and the excitation spectrum of the FRET acceptor overlaps 
with the emission spectrum of the FRET donor. Both AFPs are linked by a sensory domain, 
which undergoes a conformational change upon metabolite binding (Constantinou and Polizzi, 
2013; Frommer et al., 2009; Michener et al., 2012; Schallmey et al., 2014). Thereupon, both 
AFPs change their position relatively to each other either inducing or inhibiting FRET. The ratio 
of the intensity of emitted fluorescence of FRET acceptor and donor even allows the quantitative 
estimation of the metabolite concentration, which presents one great advantage of this biosensor 
type (Constantinou and Polizzi, 2013; Frommer et al., 2009). During the last decade, a broad 
range of FRET-based biosensors has been constructed for sensing sugars (Behjousiar et al., 2012; 
Bermejo et al., 2011), amino acids (Behjousiar et al., 2012; Gruenwald et al., 2012; Okada et al., 
2009), ions (Hessels and Merkx, 2015), redox states (Yano et al., 2010), hydrogen peroxide 
(Bilan et al., 2013) or oxygen (Potzkei et al., 2012). Helpful platforms for the construction of 
FRET sensors are the Protein Data Bank (PDB; http://www.rcsb.org/pdb/home/home.do (Berman 
et al., 2000)) or the FRETView software (http://turroserver.chem.columbia 
.edu/fretview/index.html (Stevens et al., 2007)). Although the amount of functional FRET-based 
biosensors promises a high success rate, the low predictability of conformational change of the 
sensory domain upon metabolite-binding and the resulting change of the FRET ratio render 
design efforts rather empirical (Constantinou and Polizzi, 2013; Frommer et al., 2009). 
Furthermore, the pH, ionic strength, temperature, buffer salts and other metabolites can impact 
the FRET ratio, which have to be considered using this sensor type for quantitative measurements 
(Moussa et al., 2014; Okumoto et al., 2012). In the last years, FRET-based biosensors have been 
used to study fundamental questions based on intracellular metabolite concentrations of 
mammalian, plant or microbial cells (Michener et al., 2012). In addition, they are proposed to be 
of high value for monitoring biotechnological processes due to their short signal response time 
(Constantinou and Polizzi, 2013). However, no application during HT strain development has 
been reported so far. Although binding affinities might be engineered, existing FRET-based 
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biosensors are highly sensitive and respond mainly to changes in the nM or µM scale, which 
render these sensors unfeasible for metabolic engineering approaches. 
2.4.3 Transcription factor-based biosensors 
The allosteric control of transcriptional regulators provides a highly interesting mechanism for 
metabolite detection, which has widely been exploited for the construction of genetically-
encoded biosensors (Mahr and Frunzke, 2016; Schallmey et al., 2014; Zhang et al., 2015b). 
Metabolite-responsive transcription factors (TFs) change their conformation upon effector 
binding, which in turn leads to their attachment to the TF-binding site recruiting the RNA 
polymerase for transcription initiation (Fig. 2.4). Beside small molecule recognition, 
transcriptional regulators have also been reported to control gene expression in response to ions, 
physical parameters (temperature, pH), protein-protein interactions or protein modifications 
(Mahr and Frunzke, 2016). For microorganisms, global databases like DBD 
(www.transcriptionfactor.org (Wilson et al., 2008)) as well as species-specific platforms such as 
CMRegNet (http://www.lgcm.icb.ufmg.br/cmregnet/ (Abreu et al., 2015)) for corynebacterial and 
mycobacterial species exist, which summarize the broad landscape of transcriptional regulators in 
bacteria and contribute valuable details for the construction of TF-based biosensors (Mahr and 
Frunzke, 2016).  
Transcriptional regulator-based biosensors were first successfully developed for the detection of 
toxic chemicals or ions as environmental pollutants (Fernandez-Lopez et al., 2015; Merulla et al., 
2013; van der Meer and Belkin, 2010). In the last years, their broad applicability was also used to 
study dynamics in bacterial cells at the single cell level (Kiviet et al., 2014; Mustafi et al., 2014) 
or for diverse biotechnological applications (Liu et al., 2015a; Mahr and Frunzke, 2016; 
Schallmey et al., 2014; Zhang et al., 2015b). By linking the metabolite-responsive TF-promoter 
pair to an easy screenable (e.g. fluorescence) or selectable (e.g. antibiotic or auxotrophic marker) 
phenotype, HT strain development based on genome-wide random or transposon mutagenesis has 
become feasible and effective for the isolation of cells with an increased intracellular metabolite 
concentration. This strategy was successfully applied to improve the production of succinate 
(Dietrich et al., 2013), branched-chain amino acids (Mustafi et al., 2012), L-lysine (Binder et al., 
2012), butanol as well as linear and branched-chain alcohols (Dietrich et al., 2013), benzoic acids 
(van Sint Fiet et al., 2006) or ß-ketoadipate (Dietrich et al., 2013). Furthermore, TF-based 
biosensors are also of high interest to screen enzyme libraries for desired characteristics 
16  Introduction 
(Schendzielorz et al., 2014; Siedler et al., 2014a; Siedler et al., 2014b; Uchiyama and Miyazaki, 
2010a). Applied in synthetic regulatory circuits, transcriptional regulators proved to be effective 
tools for the dynamical control and balance of metabolic fluxes for improved product formation. 
This strategy was efficiently implemented to regulate acyl-CoA and ethanol biosynthesis for the 
enhanced production of fatty acid ethyl ester (Zhang et al., 2012) or to improve malonyl-CoA 
levels for malonyl-CoA derived products (Liu et al., 2015b; Xu et al., 2014). The broad 
applicability of transcriptional regulator-based biosensors features the great success of these 
valuable sensor devices. However, the low number of well-characterized TF-promoter pairs, the 
low orthogonality of sensor constructs, the inappropriate characteristics of the biosensor in terms 
of specificity, sensitivity or dynamic range as well as the requirement to sense non-native and 
non-natural products requires improvement. 
2.5 Aims of this work 
Although nature provides a diversity of transcriptional regulator-promoter pairs available for the 
construction of biosensors, the identification of suitable candidates for the detection of desired 
metabolites often turns out to be laborious and time-consuming. For this reason, one aim of this 
work is the development of an efficient HT strategy to screen promoter libraries for appropriate 
sensor devices. Based on the Alon library, which consists of more than 2000 different 
Escherichia coli promoter-gfpmut2 fusions and hence, readily available sensor devices, a 
workflow will be developed using fluorescent-activated cell sorting (FACS) to screen for 
galactose and L-phenylalanine-responsive promoters, which might be used for the development 
of biosensors. In the following, selected candidates will be chosen in order to study the influence 
of the biosensor architecture on the sensor’s characteristics. To this end, comparative analysis of 
different sensor constructs will be performed. Finally, identified L-phenylalanine-responsive 
biosensors shall be tested for applicability during FACS HT screening of L-phenylalanine 
producers after random mutagenesis of E. coli strains.  
Adaptive laboratory evolution (ALE) is an interesting opportunity for the biotechnological 
improvement of production strains to identify novel and non-intuitive mutations by selecting at 
the same time against detrimental mutations. So far, however, ALE has only been applied to easy 
selectable or fitness-linked phenotypes. For this reason, another aim of this work will be the 
establishment of a biosensor-driven adaptive evolution strategy for improving the production of 
metabolites not linked to a directly selectable phenotype e.g. amino acids. The novel approach 
Introduction  17 
 
will be tested using the Lrp biosensor to improve e.g. L-valine production. By iteratively 
imposing an artificial selective pressure on cells with a high sensor output using FACS, clones 
with intracellularly increased L-valine levels shall be enriched. Evolved clones will 
comparatively be analyzed and mutations revealed by whole genome sequencing will then be re-
introduced into the non-evolved strain to identify whether they are beneficial for L-valine 
production. This strategy will also be examined for the production of other biotechnological 
interesting metabolites.  
The application of biosensors for monitoring metabolite production at the single cell level can 
reveal interesting dynamics as well as inefficient subpopulations. In live cell imaging studies, the 
Lrp biosensor will be applied to investigate single cell growth and production of C. glutamicum 
ΔaceE.  
18  Results 
3 RESULTS 
The overall topic of this PhD thesis was the development of transcriptional regulator-based 
biosensors for biotechnological interesting applications. The results were summarized in two 
published papers, one submitted manuscript and one manuscript that will be submitted in the near 
future. Furthermore, recent efforts in this research field were summarized in two scientific 
reviews.  
In a first study, the recently developed Lrp biosensor for the visualization of intracellular 
methionine and branched-chain amino acids was applied to monitor single-cell metabolite 
production of the L-valine producer strain C. glutamicum ΔaceE and gradually engineered 
derivatives. The publication “Application of a genetically encoded biosensor for live cell imaging 
of L-valine production in pyruvate dehydrogenase complex-deficient Corynebacterium 
glutamicum strains” describes the detection of cell-to-cell variations using the Lrp biosensor, 
which may occur during bioprocesses. Interestingly, live cell imaging analyses in microfluidic 
chip devices revealed the formation of different types of non-producing cells as well as the 
formation of subpopulations in the presence of low amounts of complex medium compounds.  
Adaptive laboratory evolution (ALE) has widely been applied to improve diverse characteristics 
of production strains. The publication “Biosensor-driven adaptive laboratory evolution of L-
valine production in Corynebacterium glutamicum” describes the application of the Lrp biosensor 
to improve growth and L-valine production of C. glutamicum ΔaceE by iteratively cultivating 
and selecting cells with the highest fluorescent output using FACS. This strategy proved likewise 
successful to reduce by-product formation. Out of seven emerged mutations, four were 
reintroduced as single mutations into the non-evolved ΔaceE strain and were revealed to increase 
L-valine production or to reduce by-product formation.  
During the biosensor-driven adaptive evolution, one mutation (ureD-E188*) arose leading to the 
formation of a truncated UreD protein, which was revealed to significantly increase L-valine 
production by about 100%. In previous studies, the lack of the essential accessory protein UreD 
was described to inactivate urease leading to reduced levels of the urea degradation products 
carbon dioxide and ammonia. The manuscript “Urease inactivity increases L-valine production in 
Corynebacterium glutamicum” presents a combination of gene deletion studies, batch 
fermentation with CO2 aeration and pH shifts, as well as DNA microarray analysis, which 
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revealed the pH-dependency of growth and production, and the impairment of anaplerosis under 
reduced CO2/HCO3- levels increasing the pyruvate supply for L-valine production.  
The natural abundance of transcriptional regulator sensing metabolites often overwhelms the 
decision of suitable biosensor candidates. To this end, we developed a HT strategy for the fast 
and easy detection of novel sensors, which is presented in the manuscript “Screening of an 
Escherichia coli promoter library for a phenylalanine biosensor”. The approach is based on the 
pooled Alon library consisting of about 2000 different E. coli promoter-gfpmut2 fusions and 
hence, readily available sensor devices. By toggled rounds of positive and negative selection 
using FACS, galactose and phenylalanine-responsive promoters were successfully enriched. 
Based on the enriched phenylalanine-responsive promoter of mtr, different biosensor 
architectures were constructed and characterized. One mtr biosensor was successfully applied for 
FACS HT screening of a randomly mutagenized E. coli MG1655 library for phenylalanine 
producing strains.  
Throughout the last years, the development and application of transcription-factor-based 
biosensors has widely expanded for biotechnological applications. In the review “Transcription 
factor-based biosensors in biotechnology: current state and future prospects”, the recent process 
in this research field is summarized. The review provides a detailed overview of biosensors 
applied in biotechnological strain development and screening approaches. Furthermore, current 
efforts in the fields of high-throughput screening, dynamic pathway control by regulatory 
circuits, biosensor-driven adaptive evolution or single-cell analysis are highlighted. In addition, 
the review describes a broad range of recent studies, which deal with the engineering of 
biosensors for altered specificities and dynamic ranges, improved or reduced sensitivity as well 
as achieved orthogonality. Finally, the review emphasizes the integration of Omics and NGS 
techniques to expand the possibilities for biosensor development and future applications.  
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4 DISCUSSION 
4.1  Biosensors – valuable tools for biotechnology 
4.1.1 Screening of nature’s toolbox for novel sensor candidates 
Microorganisms possess a plethora of natural sensor devices (e.g. transcriptional regulators, 
riboswitches or enzymes) for sensing the broad range of intrinsic and extrinsic stimuli. This 
ability allows for a quick adaption to the changing availability of nutrients and other cellular 
requirements, or to altered physical and environmental conditions. The principle of sensing 
metabolites by transcriptional regulators has been proven to be of high value for a variety of 
biotechnological applications including the visualization of inconspicuous metabolites during 
bioprocesses, the control of biosynthetic pathways as regulatory circuits, and the development of 
production strains (Liu et al., 2015a; Mahr and Frunzke, 2016; Zhang et al., 2015b). To date, 
however, only a few regulators and their corresponding target promoters have been well 
characterized, which constitutes an important prerequisite to choose a suitable sensor candidate 
for the desired application. Hence, efficient strategies are in demand for the fast identification of 
appropriate effector-responsive transcriptional regulators and target promoters. To this end, an 
elaborated FACS-based workflow was developed in this study to screen libraries of promoters 
fused to genes encoding auto-fluorescent proteins (chapter 3.4). The Alon library consisting of 
about 2000 different promoter-gfpmut2 fusions in E. coli presents a valuable tool with readily 
available sensor devices (Zaslaver et al., 2006). Using FACS, metabolite-responsive promoters 
were enriched from the pooled library by toggled rounds of positive and negative selection. This 
novel strategy was successfully applied to screen for galactose- and L-phenylalanine-responsive 
promoter-gfpmut2 fusions.  
According to the statement “You get what you screen for” (Schmidt-Dannert and Arnold, 1999), 
the efficient screening for metabolite-responsive promoters by FACS requires a well-considered 
protocol. Here, the eventual application of the biosensor plays an important role: Due to the 
diverse underlying dynamics of gene regulatory mechanisms in response to effector molecules, 
the time point for sorting of cells as well as the composition of the cultivation medium may 
strongly impact the outcome of the screening process. Furthermore, the choice of the sorting gate 
may decide about the characteristics of the enriched promoters in terms of background activity 
and the dynamic range. Beyond that, the toggled rounds of positive and negative selection turned 
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out to be efficient to get rid of constitutively active promoters of e.g. house-keeping genes. 
Likewise, this FACS-based strategy is proposed to enable screening for transcriptional repressors 
by inverting the toggled rounds of selection.  
Besides FACS, automated robotic platforms allow for the HT screening of strain libraries clone 
by clone to identify variants with the desired phenotype or function. Screening clone by clone 
avoids on the one hand the loss of appropriate strains, which is more probable during FACS 
screening. One the other hand, the high screening capacity of about 80.000 cells per second and 
the potential to sort 10.000 cells within the same time argue strongly for the application of FACS 
reducing likewise costs and time (Dietrich et al., 2010). Furthermore, the outcome of screening 
promoter libraries depends strongly on the pre-adjusted conditions (e.g. medium, time, etc.). 
Here, FACS allows for the fast and easy screening of libraries under different conditions within a 
few minutes in contrast to screening clone by clone. One limitation of the FACS-based strategy is 
the availability of a suitable and easily accessible library of promoter fusions. Considering 
biotechnological applications, appropriate and comprehensive collections exist for the 
biotechnological interesting microbes E. coli (Zaslaver et al., 2006) and S. cerevisiae (Newman et 
al., 2006). Nevertheless, the decreasing costs of gene synthesis and robot-based production lines 
allow for the generation of such libraries in a manageable manner. Furthermore, the integration of 
promoter libraries in different organisms might also enable the screening for orthogonal sensor 
devices.  
A similar strategy was developed by Uchiyama and co-workers in order to identify catabolic 
genes from environmental metagenomes (Uchiyama and Miyazaki, 2010b; Uchiyama and 
Watanabe, 2008). By fusing fragments of a metagenomic library to a reporter gene (e.g. gfp) in 
an operon-trap vector, HT screening for metabolically-relevant fragments using FACS became 
possible. This strategy might likewise be exploited to screen metagenomic libraries for effector-
responsive transcriptional regulator-promoter pairs. Furthermore, comparative transcriptome 
analysis like DNA microarrays or RNA sequencing may also contribute to the identification of, 
so far, uncharacterized metabolite-responsive genes, of which the regulatory mechanism might be 
exploited as biosensor devices (Dahl et al., 2013; Mahr and Frunzke, 2016).  
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4.1.2 The application of biosensors for single cell studies 
Besides their valuable application for metabolic engineering purposes, genetically-encoded 
biosensors are excellent tools to visualize the development of cell-to-cell heterogeneity e.g. in 
bioprocesses (Delvigne et al., 2009; Mustafi et al., 2014; Vasdekis and Stephanopoulos, 2015). 
Typically, the development of phenotypic pattern such as inefficient subpopulations, which may 
affect the performance and stability of bioprocesses, is neglected by the use of bulk analyses 
(Delvigne and Goffin, 2014; Delvigne et al., 2014; Müller et al., 2010). In this study, the Lrp 
biosensor was applied to study phenotypic pattern of the L-valine producer C. glutamicum ΔaceE 
and derivatives by live cell imaging (chapter 3.1, (Mustafi et al., 2014)). In contrast to large-scale 
cultivations, 2D microfluidic chip devices offer the great advantage to analyze single cells in a 
monolayer with high spatial and temporal resolution and enable likewise the cultivation at 
environmental constant and defined conditions (Grünberger et al., 2012; Grünberger et al., 2014). 
Interestingly, the analysis of the growth-decoupled L-valine producer strain ΔaceE and 
derivatives revealed the formation of non-producing subpopulations in the production phase upon 
addition of small amounts of complex medium compounds as often used during production 
processes. While most cells switched from growth to production (depicted by the fluorescent 
signal of the biosensor), single cells continued growing and/or switched to production at a later 
time point (Fig. 5 in chapter 3.1, (Mustafi et al., 2014)). A similar phenotypic pattern of 
fluorescent and non-fluorescent sensor ΔaceE cells was observed during flow cytometric analysis 
of shake flask cultures (data not shown). Although the origin for phenotypic heterogeneity was 
ascribed to the used complex medium compounds, the responsible triggers as well as the 
underlying physiological and molecular basis remain unknown due to the lack of readily 
available single cell analysis tools interfacing with FACS or microfluidics.  
So far, different staining techniques interfacing with FACS proved efficient to discriminate 
between living, lysed or dead cells, or may detect variations in the DNA content or membrane 
potential of cellular populations (Langemann et al., 2016; Neumeyer et al., 2013). Furthermore, 
workflows have been established to analyze the proteome of FACS-isolated subpopulations by 
mass spectrometry (Jahn et al., 2013; Jehmlich et al., 2010). Even mass-spectrometric 
measurements of various metabolites in single cells are nowadays possible (Amantonico et al., 
2008; Heinemann and Zenobi, 2011; Rubakhin et al., 2013). In the future, the interplay of 
biosensors with next generation sequencing techniques (e.g. RNA-seq) and high-resolution 
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proteomics or metabolomics might provide novel and profitable insights into the formation of 
subpopulation.  
4.1.3 Limitations of transcriptional regulator-based biosensors 
Within recent years, biosensors based on transcriptional regulators have proven to be of great 
benefit for the establishment of efficient microbial cell factories by improving production strains 
or by identifying inefficient subpopulations in bioprocesses (Binder et al., 2012; Chou and 
Keasling, 2013; Delvigne et al., 2009; Dietrich et al., 2013; Mahr et al., 2015; Mustafi et al., 
2012; Mustafi et al., 2014; Zhang et al., 2012). The drawbacks and limits of genetically-encoded 
biosensors, however, are often neglected during application, but have to be considered for the 
correct interpretation of the obtained results.  
The mechanism of transcriptional regulators to transfer the intracellular presence of effector 
metabolites into the expression of target genes is based on a complex hierarchy of molecular 
interactions and biochemical reactions. This includes metabolite sensing, transcriptional and 
translational processes, and the interference between different regulatory networks. In E. coli, 
transcription typically runs with a speed of 40-80 base pairs per second, while translation 
proceeds at about 20 amino acids per second (Dennis and Bremer, 1974; Young and Bremer, 
1976). For this reason, the information on a defined amount of effector metabolites at a defined 
time-point is transmitted as time-delayed response. Moreover, the metabolite-dependent 
expression of a gene encoding a fluorescent protein results in a further delayed optical response 
due to protein folding and the maturation of the chromophore. In the case of eYFP, the 
maturation requires about seven minutes in E. coli at 37°C, while the maturation of Venus was 
measured to proceed within two minutes under the same conditions (Iizuka et al., 2011; Nagai et 
al., 2002). In comparison, FRET-based biosensors or engineered riboswitches, binding 
fluorophores upon metabolite recognition, reveal an improved temporal resolution of effector 
metabolites as ligand-binding directly results in the transmission of fluorescence as consequence 
of a conformational change (Michener et al., 2012; Mohsin and Ahmad, 2014; Potzkei et al., 
2012; Schallmey et al., 2014; You et al., 2015; Zhang et al., 2015b).  
For quantitative intracellular measurements, fastidious calibration and characterization of the 
biosensor’s performance are required to describe the relationship between input concentration 
and output signal under highly defined conditions (Dietrich et al., 2010). To this end, the effector 
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molecule must enter the cell. This, however, is often not possible due to the lack of uptake 
systems or inappropriate physical characteristics of the effector to cross the membrane (e.g. high 
hydrophilicity). In contrast to TF-based biosensors, FRET-based biosensors allow for quantitative 
analyses upon intensive calibration and definition of assay conditions. This is difficult to achieve 
for TF-based biosensors due to the high number of mechanisms involved in the expression of 
target genes upon metabolite sensing (Constantinou and Polizzi, 2013; Michener et al., 2012). In 
theory, quantitative intracellular analysis would need the incorporation of any intrinsic and 
extrinsic factor affecting gene expression or fluorescence development, which is hardly feasible 
in living organism due to e.g. gene expression noise (Carey et al., 2013; Elowitz and Leibler, 
2000; Keren et al., 2015; Sanchez et al., 2013). Beyond that, TF-based biosensors report on the 
intracellular metabolite level, which is a prerequisite for an application in FACS screenings. Most 
biotechnological applications, however, aim to maximize the amount of excreted product in the 
supernatant to reduce costs during downstream processing without an interest for intracellular 
metabolite levels (Delvigne et al., 2015). For this reason, a quantification of intracellular 
metabolites is negligible in most cases. Nevertheless, TF-based biosensors report on the relative 
intracellular metabolite concentration in a reliable way, which allows for the discrimination of 
cells or populations with different productivity during HT screening or monitoring of 
bioprocesses using FC/FACS or fluorescence microscopy. 
Traditionally, the biosensor construct consists of the transcriptional regulator and the target 
promoter controlling the expression of an actuator gene encoded on a plasmid. During the 
development of the mtr biosensor for detecting L-phenylalanine in E. coli, different designs of 
the biosensor with and without the transcriptional regulator were found to drastically affect the 
biosensor’s performance characteristics. On the one hand, the additional expression of the 
transcription factor avoids titration effects of the native regulator and allows for heterologous 
gene expression. On the other hand, the increased numbers of TF molecules can have a strong 
impact on the bacterial physiology by skewing the activity of the transcriptional network, 
especially in the case of global regulators controlling the expression of various target genes. This 
effect can even be multiplied by the amount of plasmid copies in the case of plasmid-based 
expression of sensor circuits (Delvigne et al., 2015). To avoid the interference with the native 
regulatory network, to prevent the multiplication of gene expression noise or to reliably study the 
dimensions of phenotypic heterogeneity, the use of low-copy number plasmids or chromosomal 
108  Discussion 
integration have shown to be of great benefit (Freed et al., 2008; Mustafi et al., 2014; Silander et 
al., 2012). In addition, the different architectures of the mtr biosensor in this study (chapter 3.4) 
demonstrated that an additional copy of the regulator is often not necessary and may even lead to 
improved performance characteristics. For this reason, it might be advantageous to test different 
biosensor designs e.g. with and without the additional expression of a native regulator in advance. 
Further strategies to alter the performance characteristics of a biosensor are discussed in chapter 
4.1.4 (“Engineering of biosensors for improved and desired characteristics”). 
For the visualization of intracellular metabolites, biosensors usually drive the production of an 
auto-fluorescent protein, e.g. green fluorescent protein (GFP) and derivatives. The drawback of 
GFP-derived fluorescent proteins, however, consists in the requirement of oxygen for the 
formation of the chromophore (Craggs, 2009), which excludes their reliable application during 
micro- and anaerobic cultivation. Alternatively, Drepper and co-workers developed a set of flavin 
mononucleotide (FMN)-based fluorescent proteins (FbFPs) based on the photoactive light 
oxygen voltage (LOV)-domain of blue-light photoreceptors from Bacillus subtilis and 
Pseudomonas putida, which enable fluorescent signaling in the absence of oxygen (Drepper et 
al., 2007; Drepper et al., 2010; Walter et al., 2012). Their low brightness, quantum yield and 
strongly reduced thermal or photostability in contrast to GFP derivatives have indeed been 
reported and addressed in different studies (Christie et al., 2012; Song et al., 2013; Wingen et al., 
2014), however, the broad applicability of FbFP is still hampered (Mukherjee and Schroeder, 
2015). Traditionally, GFP feature high stability with a half-life of more than 24 hours. Highly 
stable fluorescent proteins prevent dynamic measurements by the accumulation of reporter 
proteins within the cell. Engineered GFP derivatives already exhibit reduced photostability 
(Shaner et al., 2005). Additionally, the destabilization of auto-fluorescent proteins using variants 
of ssrA tags, which are recognized by cytoplasmic proteases, revealed further improvement of 
dynamic measurements of fluorescent signals in various microbes (Andersen et al., 1998; 
Hentschel et al., 2013; Triccas et al., 2002).  
The application of biosensors for live cell imaging studies in microfluidic devices offers the 
possibility to study microbial population dynamics at the single cell level (Mustafi et al., 2014). 
The rate of iterative excitation should be kept a minimum – especially excitation light of the 
energy-rich short wavelength – to avoid phototoxic effects e.g. DNA damage by free radicals 
(Haselgrübler et al., 2014; Lipovsky et al., 2010; NPG-Editorial, 2013; Waters, 2013). Especially 
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the performance of multicolor experiments of different parameters in parallel using several 
fluorescent proteins can provide an immense physiological burden on the living cell (Schlüter et 
al., 2015; Shaner et al., 2005). To reduce the artifacts of exposed light, fluorescent proteins have 
to be carefully chosen according to their respective application and the organism under study. 
4.1.4 Engineering of biosensors for improved and desired characteristics 
The different designs of the mtr biosensor for L-phenylalanine detection revealed a significant 
influence of the architecture on the sensor’s performance characteristics including the dynamic 
range, sensitivity and background signal (chapter 3.4). Extending beyond, diverse studies 
demonstrated that engineering of biosensors according to the respective purpose can become 
feasible due to the modular architecture of promoter regions (Blazeck and Alper, 2013) and 
transcriptional regulators (Galvao et al., 2007; Zhang et al., 2015b).  
The mtr biosensor, which consists of the native promoter of mtr fused to the gene encoding the 
fluorescent protein Venus (Fig. 4.1.4.1 A), features a maximal fivefold increased fluorescent 
signal in response to L-phenylalanine (chapter 3.4). Other biosensors such as the pSenLys sensor 
for sensing L-lysine and the DcuR/DcuS-based or PcaR-based sensor for sensing dicarboxylic 
acids showed similar dynamic ranges of signal output (six- to 15-fold) in the presence of the 
respective effector molecule (Binder et al., 2012; Dietrich et al., 2013). The Lrp biosensor 
featured an about tenfold increased signal in response to L-isoleucine, twelvefold to L-valine, 22-
fold to L-leucine and an even 78-fold dynamic range to L-methionine accumulation (Mustafi et 
al., 2012). A broad dynamic range as shown for L-methionine detection by the Lrp sensor is 
desired to reliably distinguish between different productive cells by FC or fluorescence 
microscopy. To enhance fatty acid sensing in E. coli, Zhang and coworkers introduced the TF-
binding sites of the transcriptional regulator FadR into the strong phage promoters of lambda (PL) 
and T7 (PA1), thereby increasing the dynamic range up to 1000-fold (Zhang et al., 2012). 
Similarly, Lutz and Bujard engineered the tight regulation of the TetR/O system for sensing 
anhydrotetracycline over a 5000-fold range (Lutz and Bujard, 1997). A similar approach could 
also be considered for improving the dynamic range of the mtr biosensor in response to L-
phenylalanine. This could be achieved by introducing one or two TyrR-binding sites up- and/or 
downstream of the -35 region of a strong phage promoter e.g. the well-studied lambda phage 
promoter (Fig. 4.1.4.1 B).  
110  Discussion 
 
Fig. 4.1.4.1 The mtr biosensor and potential designs for improved and desired performance 
characteristics. A. The mtr biosensor is based on the native promoter Pmtr fused to the gene 
encoding the fluorescent protein Venus. The native promoter Pmtr consists of a weak and a strong 
TyrR box and two TrpR boxes. For L-phenylalanine (F)-mediated activation of gene expression, 
TyrR binds as dimer to the strong TyrR-binding site and recruits RNA-polymerase. L-tyrosine 
(Y)-mediated gene expression requires binding of TyrR as hexamer to the weak and strong TyrR 
boxes. B. Introduction of the strong TyrR box between the -10 and -35 region of the λ phage 
promoter PL might improve the dynamic range and might likewise reduce the background noise. 
C. Randomization of TF-binding sites (shaded) by e.g. error-prone PCR results in a diversity of 
promoter derivatives of which mtr promoters with a Kd in the low mM range might be screened. 
D. The recognition of L-tyrosine as effector of the mtr promoter might be inhibited by removing 
or replacing the weak TyrR box. 
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Reporter systems with a dynamic response in the µM to mM range are of high value for 
biotechnological applications (Eggeling et al., 2015). For this reason, the sensitivity, which 
describes the rate of increase in reporter output to the amount of effector molecules, presents an 
important factor for the performance of the biosensor (Dietrich et al., 2010). To improve the 
sensitivity of the regulator BenR of P. putida KT2440 towards 3-methylbenzoate, Silva-Rocha 
and de Lorenzo successfully completed a second truncated operator motif within the Pb promoter 
(Silva-Rocha and de Lorenzo, 2012). Likewise, the addition of several additional operator motifs 
was proposed to increase the sensitivity (Tabor et al., 2009). The mtr biosensor, however, is 
already highly sensitive to L-phenylalanine in the µM range. The promoter of mtr contains TrpR-
binding sites for L-tryptophan-mediated repression and upstream located TyrR-binding sites for 
L-phenylalanine- and L-tyrosine-mediated activation (Pittard et al., 2005). Engineering of TF-
binding sites e.g. by error prone PCR, and screening for biosensors featuring a Kd in the low mM 
range might improve the biosensor’s potential for the application in strains with industrially 
interesting L-phenylalanine or L-tyrosine production (Fig. 4.1.4.1 C). 
The specificity of a biosensor for a defined effector molecule is important to reduce false-positive 
isolates during FACS HT screening or to avoid the misinterpretation of live cell imaging or 
bioprocess studies. As the mtr biosensor senses the aromatic amino acids L-phenylalanine and L-
tyrosine, the isolation of L-tyrosine and L-phenylalanine producers is likely. The case of the mtr 
biosensor fortunately comprises an easy solution of this dilemma: L-tyrosine-mediated activation 
of the mtr promoter requires binding of TyrR as hexamer to the strong and the weak box (TF-
binding site) in contrast to L-phenylalanine detection, which only requires binding to the strong 
box (Pittard et al., 2005; Sarsero and Pittard, 1991). By removing or replacing the weak box, the 
activation of gene expression upon L-tyrosine recognition may be eliminated (Fig. 4.1.4.1 D).  
The diversity of biotechnologically produced metabolites challenges the expansion of biosensors 
for non-native and non-natural products (Schallmey et al., 2014). Theoretically, the modular 
architecture of transcriptional regulators (metabolite- and DNA-binding domains) enables 
engineering of the biosensor for improved, altered or novel specificities (Galvao and de Lorenzo, 
2006). Different strategies proved successful to modify the ligand binding pockets of regulators 
by error-prone PCR (Wise and Kuske, 2000), chemical and saturation mutagenesis (Tang and 
Cirino, 2011; Tang et al., 2008; Tang et al., 2013) followed by HT screening of mutant libraries, 
or computational modelling based on crystal structures (Combs et al., 2013; Fry et al., 2010; 
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Looger et al., 2003; Mandell and Kortemme, 2009). A further approach relies on the artificial 
assembly of enzymatic metabolite-binding domains and the AraC DNA-binding domain e.g. for 
sensing isopentenyl diphosphate (Chou and Keasling, 2013). Furthermore, the orthogonality of 
biological functions still provides a bottleneck for metabolic engineering strategies, which often 
rely on heterologous pathways for the formation of non-native products (Mahr and Frunzke, 
2016; Schallmey et al., 2014; Zhang et al., 2015b). For the functional transfer of biological parts 
between different host species, the expression from native promoters of the acceptor organisms as 
well as codon-optimization may be highly beneficial (Gopal and Kumar, 2013; Gustafsson et al., 
2004; Sorensen and Mortensen, 2005). In addition, engineering the contact between the non-
native regulator or promoter, and the native transcriptional or translational machinery (e.g. α-
subunit of the RNA polymerase, DNA binding sites), which is necessary for metabolite 
recognition and signal transduction, might be interesting targets for improving orthogonality (Fig. 
4.1.4.2).  
 
Fig. 4.1.4.2 The interaction between the transcription factor (TF, gray), the promoter Px and the 
RNA polymerase (green). Potential targets for the improvement of the recognition of a non-
native TF or native/non-native promoter Px by the native transcription machinery: 1. The 
interaction between the α-subunit of the RNA-polymerase and the TF. 2. The recognition of the -
10 and -35 region and the σ-factor. 3. The recognition between the TF and the TF-binding site 
(operator). 4. The distance between the -35 region and the TF-binding site.  
In previous studies, the equipment with eukaryotic-specific signals (nuclear localization signal, 
transcriptional activation domain, etc.) proved successful to transfer bacterial regulators to yeast 
or mammalian cells allowing for S-adenosylmethionine, fatty acids or 2,4-diacetylphloroglucinol 
sensing (Ellis and Wolfgang, 2012; Stanton et al., 2014; Teo and Chang, 2014; Umeyama et al., 
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2013). Nevertheless, efficient strategies are required to improve the orthogonality of 
transcriptional regulators and to understand the detailed interactions between the regulator, 
metabolite, operator and RNA polymerase (Charoensawan et al., 2015; Zhang et al., 2015b). 
4.2 Novel strategies for engineering microbial cell factories  
Rational metabolic engineering approaches mainly focus on the development of biosynthetic 
pathways, the sufficient supply with precursors, the import of substrates or the export of products 
as well as the degradation of those. A global and comprehensive consideration of the impact on 
microbial physiology is often neglected due to the high complexity of carbon and energy fluxes 
in living organisms. In addition, there are still many unknown and uncharacterized gene 
activities, regulatory mechanisms and metabolic fluxes, which obscure a systems-level insight 
into the global metabolic landscape. For this reason, novel metabolic engineering strategies and 
tools are in demand, which incorporate the entire physiology of the organism for improved 
production phenotypes. Here, adaptive laboratory evolution approaches as well as random 
mutagenesis of the entire genome followed by an elaborated screening strategy enabled the fast 
identification of non-intuitive targets for improving microbial cell factories (Atsumi et al., 2010; 
Baek et al., 2015; Fong et al., 2005; Mahr et al., 2015; Park et al., 2014; Sandberg et al., 2014; 
Xie et al., 2015). Further valuable contributions of both strategies for metabolic engineering 
purposes are highlighted in the following reviews (Abatemarco et al., 2013; Dietrich et al., 2010; 
Eggeling et al., 2015; Portnoy et al., 2011). Recently, the application of genetically-encoded 
biosensors revealed the expansion of the utility of these strategies to engineer biotechnological 
interesting, but inconspicuous metabolite production (Fig. 4.2).  
4.2.1 Application of biosensors for high-throughput screening 
Since the start of microbial engineering in the early last century, the diversification of genetic 
elements mimicking the processes of evolution and the consequential screening for desired 
functions have proven successful to develop novel and improved biotechnologically interesting 
phenotypes such as increased metabolite production (Becker and Wittmann, 2015; Dietrich et al., 
2010; Parekh et al., 2000). The low-throughput (<103 individuals per day) of analytical 
techniques such as chromatography, mass or nuclear magnetic resonance spectroscopy, however, 
hamper screening of large mutant libraries. Here, the application of genetically-encoded 
biosensors visualizing intracellular metabolites, which allows for interfacing with FACS, 
revolutionized the HT screening of inconspicuous, small metabolites.  
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Fig. 4.2 Schematic of A. FACS HT screening of mutagenized sensor cells and B. biosensor-
driven adaptive laboratory evolution. A. For FACS HT screening, sensor containing cells are 
randomly mutagenized by chemical mutagens such as MNNG. Cells are analyzed by FC and 
those with the highest fluorescent output are isolated by FACS as single clones on agar plates. B. 
For the biosensor-driven adaptive laboratory evolution, sensor cells with the top fluorescent 
output are iteratively isolated and re-cultivated. Then, high fluorescent sensor cells are spotted as 
single clones on agar plates. A. and B. Isolated single clones are re-cultivated in microtiter plates 
and analyzed for growth and fluorescence. The supernatant is assessed for the production by 
uHPLC. Subsequently, cells featuring desired characteristics are sequenced.  
In a proof-of-principle study, the mtr biosensor for the detection of L-phenylalanine was used to 
screen a chemically mutagenized library of E. coli K-12 MG1655 cells using FACS (chapter 3.4). 
After mutagenesis, biosensor containing cells were screened by FACS, which allows for 
screening of about 80.000 cells per second and the possibility to isolate about 10.000 clones 
within the same time span (Fig. 4.2 A). Optionally, several enrichment steps with and without 
intermediate cultivation can be included to reduce false-positive clones. Following the isolation 
of single clones, a second screening step is of crucial importance as the increase of throughput is 
typically accompanied by reduced sensitivity and the neglect of small variations. Typically, 
Discussion  115 
 
FACS-based screens are affected by the isolation of false-positive clones (22% this study; 77% 
(Mustafi et al., 2012)) due to the variance of the fluorescent signal for technical issues and noisy 
gene expression (Delvigne et al., 2015; Dietrich et al., 2010; Sanchez et al., 2013). In addition, 
the enrichment of exporter gene mutations improving or reducing the ability of metabolite 
secretion as well as the occurrence of modifications within the fluorescent reporter gene may 
likewise skew the picture of the actual production capacity of the organism, which can be 
revealed by re-analysis of isolated clones.  
During screening for L-phenylalanine producers, about one third of 90 isolated mutant strains 
displayed at least two-fold up to 4.3-fold increased production titers (Fig. 4 in chapter 3.4). 
Similar studies featured a comparable fraction of positive clones (Binder et al., 2012; Mustafi et 
al., 2012). The top mutant clone excreted 160 µM L-phenylalanine into the supernatant. 
Compared to rationally engineered strains, which produce up to 300 mM (≈50 g L-1) (Backman et 
al., 1990; Rüffer et al., 2004), the outcome appears quite low. Increased levels of L-phenylalanine 
can strongly impact the growth rate (Grinter, 1998). Polen and coworkers observed that the 
addition of 5 g L-1 L-phenylalanine reduced the growth rate by a factor of two (Polen et al., 
2005). For this reason, the iterative enrichment by FACS, which was used to reduce the isolation 
of false-positive clones, might likewise select against slow growing cells impacted by increased 
L-phenylalanine production (chapter 3.4). Furthermore, the applied biosensor featured a highly 
sensitive response in the low µM range by approximating saturation in the mid-µM range. These 
performance characteristics of the biosensor consequently led to the isolation of clones with 
corresponding intracellular amino acid concentrations. Thereby, the identification of single 
clones with further increased production might be overlooked due to the high number of “low-
performance” clones. Besides L-phenylalanine, the mtr biosensor responds additionally to 
increased L-tyrosine levels. Both aromatic amino acids share a great part of their biosynthetic 
route (Sprenger, 2007). Consequently, mutations increasing prephenic acid – a precursor of both 
amino acids – enhance the production of both. In this case, the fluorescent output of the biosensor 
would be composed of the response to L-phenylalanine and L-tyrosine. Interestingly, no clone 
with significantly increased L-tyrosine production was isolated (data not shown). Altogether, the 
design of the screening process (e.g. by implementation of several enrichment steps) as well as 
the performance of the biosensor may significantly impact the outcome of FACS HT screening. 
Here, the engineering of the biosensor for reduced sensitivity, improved specificity towards L-
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phenylalanine or the increase of the dynamic range as described in chapter 4.1.4 (“Engineering of 
biosensors for improved and desired characteristics”) might be highly beneficial. For further 
limits and considerations for the application of biosensors, the reader is referred to chapter 4.1.3 
(“Limitations of transcriptional regulator-based biosensors”). 
For the establishment of the mutant E. coli library, the alkylating mutagen N-methyl-N’-nitro-N-
nitrosoguanidine (MNNG) was chosen due to ability to generate genome-wide mutations as 
observed in a variety of previous studies (Binder et al., 2012; Harper and Lee, 2012; Ohnishi et 
al., 2008). The drawback of random mutagenesis is the emergence of several hundred small 
nucleotide polymorphisms (SNPs) throughout the entire genome, which hampers the 
identification of valuable, non-intuitive mutations. For example, the top five mutants isolated by 
FACS HT screening using the mtr biosensor revealed a total of 538 SNPs, of which 310 SNPs 
resulted in amino acid exchanges or stop codons (Tab. S4.2.1.1). Interestingly, amino acid 
exchanges were found in nine genes (mtr, pheA, trpB, trpD, trpE, tyrA, tyrP, yedA, yddE), which 
are associated with the biosynthesis or transport of aromatic amino acids. To verify beneficial 
SNPs for metabolite production, a high number of single mutations have to be re-introduced into 
a cured genomic background (Binder et al., 2012), which is laborious and time-consuming. 
Elaborated strategies like “Phenotype Sequencing” based on the computational sequence analysis 
of multiple independent mutants, or a recombineering strategy interfacing with biosensors based 
on FACS have been developed to improve the identification of valuable mutations (Binder et al., 
2013; Harper et al., 2011). The interesting interplay of epistatic or synergistic mutations as 
observed during evolution-based studies (Cheng et al., 2014; Horinouchi et al., 2015; Oide et al., 
2015; Sandberg et al., 2014; Tenaillon et al., 2012) might hardly be revealed by the abundance of 
mutations.  
In addition, extensive studies using MNNG in E. coli and C. glutamicum demonstrated the 
preferential accumulation of GC to AT transitions (96.6%) and the dependency of the genomic 
context (Harper and Lee, 2012; Ohnishi et al., 2008), which strongly restricts the spectra of 
amino acid exchanges. In the mtr biosensor-based FACS HT screening of MNNG-mutagenized 
E. coli cells, for instance, 12% of all amino exchanges resulted in serine, 11% in isoleucine, and 
10% in aspartic acid, asparagine or valine (Tab. S4.2.1.2). Exchanges to glycine, tyrosine, 
tryptophan, glutamine, proline or alanine were hardly or not identified. Furthermore, amino acids 
phenylalanine, tyrosine, isoleucine, asparagine or lysine were not found to be exchanged by 
Discussion  117 
 
MNNG-mutagenesis (Tab. S4.2.1.2). This mutation spectra strongly limits the potential for the 
identification of ideal and desired protein functions e.g. enzymatic activities, feedback resistance, 
allosteric or DNA-binding capabilities, or protein-protein interactions. A broad range of 
alternative mutagens exists such as mutagenic chemicals including other alkylating agents, azides 
or base analogs (Benigni et al., 1992; Cai and Fix, 2002; Kodym and Afza, 2003; Pavlov et al., 
1991; Richardson et al., 1988), or physical mutagens like ultra-violet (UV) and electromagnetic 
radiation (gamma rays or X rays) or atmospheric and room temperature plasma (ARTP) 
mutagenesis (Kodym and Afza, 2003; Zhang et al., 2015c; Zhang et al., 2014b). However, they 
all share rather one-sided mutation spectra. Here, the diversification of single, genetic fragments 
such as catalytic domains of interesting enzymes by error-prone PCR followed by FACS HT 
screening might contribute to the identification of desired phenotypical characteristics 
(Schendzielorz et al., 2014; Siedler et al., 2014a; Siedler et al., 2014b).  
4.2.2 Biosensor-driven adaptive laboratory evolution 
In contrast to random mutagenesis, adaptive laboratory evolution (ALE) approaches driven by 
mutation and selection profit from a strongly reduced number of mutations by promoting the 
establishment of beneficial traits and selecting against detrimental mutations at the same time 
(Abatemarco et al., 2013; Harper et al., 2011; Portnoy et al., 2011). Based on a natural mutation 
frequency of 10-10 to 10-9 mutations per base pair per replication cycle and short generation times 
(Barrick and Lenski, 2013), laboratory evolution experiments of microbes allow the selection of 
beneficial phenotypical traits from a natural diversity of phenotypic characteristics. So far, 
adaptive laboratory evolution has mostly been applied to easy selectable or fitness-linked 
phenotypes by iteratively increasing environmental stress (Eckdahl et al., 2015; Lee et al., 2013; 
Marietou et al., 2014; Oide et al., 2015; Reyes et al., 2014).  
4.2.2.1 The establishment biosensor-driven adaptive laboratory evolution 
In this study, the applicability of laboratory evolution was expanded to inconspicuous, small 
metabolites by imposing an artificial selective pressure on the fluorescent output of a biosensor 
using FACS. This novel approach was successfully applied to improve production of the basal L-
valine producer strain C. glutamicum ΔaceE containing the Lrp biosensor (chapter 3.2, 
(Blombach et al., 2007; Mahr et al., 2015)). Cells with the top fluorescent output indicating 
increased L-valine production were iteratively isolated by FACS and (re-) cultivated (Fig. 4.2 B). 
As the ΔaceE strain displays a growth-decoupled L-valine production phenotype, cells were 
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iteratively sorted in the production phase after 28 hours of cultivation. Within five rounds of 
toggled sorting and cultivation, isolated evolved strains featured improved growth, on average 
about 25% increased L-valine production and three- to four-fold reduced by-product (L-alanine) 
formation. Sequencing of two isolated mutants revealed a total of seven SNPs, of which four 
(ureD-E188*, glxR-T93S, prpD2-T201I and rpsP-D30D(c90t)) were re-introduced and assessed 
in the non-evolved ΔaceE strain. All mutations featured about 15-20% increased biomass-
specific L-valine yields (YP/X). The ureD-E188* mutation even resulted in a further increased L-
valine yield of about 100%. Moreover, the reduction of L-alanine formation was attributed to a 
mutation in the cAMP-binding pocket of glxR (Mahr et al., 2015). To test the applicability of the 
biosensor-driven adaptive laboratory evolution approach to improve likewise the production of 
other metabolites, the L-leucine production strain C. glutamicum MV-Leu7 (Vogt et al., 2014) 
was additionally employed in a FACS-based evolution experiment using the Lrp biosensor (Fig. 
S4.2.2.1). In contrast to the ΔaceE strain for L-valine production, MV-Leu7 features a growth-
coupled production phenotype, which requires an altered sorting strategy. Here, sorting of cells 
with the highest fluorescent output in the early exponential phase at an OD600 of 4 proved to be 
more efficient in contrast to sorting in the stationary phase after 28 hours, which was beneficial 
for the evolution of growth-decoupled L-valine production (data not shown). Within four iterative 
evolution steps, the biomass-specific L-leucine yield YP/X increased from 0.55 to 0.81 mmol per g 
cell dry weight (CDW) by around 50% (Fig. S4.2.2.1). Interestingly, the growth rate dropped 
during the evolution experiment, which might result from the rerouting of carbon sources towards 
L-leucine production. Nevertheless, these results prove biosensor-driven adaptive laboratory 
evolution efficient and straightforward for improving production strains without a deep 
knowledge of the complex bacterial physiology. 
4.2.2.2 “You get what you screen for” 
Along with the statement “You get what you screen for” (Schmidt-Dannert and Arnold, 1999), 
the outcome of the biosensor-driven adaptive laboratory evolution approach strongly depends on 
several factors including i) the performance of the biosensor, ii) the growth- and production-
phase selected for FC analysis and sorting, iii) the medium composition, iv) the scale of 
cultivation, v) the sorting strategy and accuracy of FACS and/or vi) cultivation conditions 
affecting the living cell. 
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First of all, the performance characteristics of the biosensor seem to be of high importance: 
During evolution, no further improvement of extracellular L-valine accumulation of the evolved 
culture was observed after the fifth sorting step (Fig. 1 in chapter 3.2, (Mahr et al., 2015)). This 
observation might indicate the saturation of the biosensor response, where an increase of 
intracellular amino acid concentration does not further result in an increase of the output of the 
biosensor due to reaching the highest rate of occupation of the promoter with transcription factors 
(Bintu et al., 2005a; Bintu et al., 2005b). For this reason, biosensor-driven evolution selecting 
cells with the top fluorescent output could not further improve L-valine production using the Lrp 
biosensor. Here, engineering of the biosensor is proposed to expand the operating range of the 
biosensor-driven adaptive laboratory evolution. While the sensitivity might be reduced by e.g. 
modifying the TF-binding site of the promoter or the DNA-binding domain within the TF itself, 
the dynamic range might be enhanced e.g. by the incorporation of the Lrp operator sequence in a 
strong phage promoter (as described in chapter 4.1.4 “Engineering of biosensors for improved 
and desired characteristics”).  
The novel ALE approach proved highly successful to identify bottlenecks during the cultivation 
of the L-valine producer strain C. glutamicum ΔaceE. For instance, the identified ureD-E188* 
mutation generates a truncated, non-functional urease-accessory UreD protein. In a previous 
publication, UreD was categorized as protein of crucial importance for urease activity in order to 
degrade urea to ammonia and carbon dioxide (Nolden et al., 2000). Traditionally, urea serves as 
nitrogen source in the CGXII cultivation medium (Keilhauer et al., 1993). Interestingly, the lack 
of urea further increased L-valine production of the ΔaceE strain (Fig. 4 and 5 in chapter 3.2, 
(Mahr et al., 2015). Additional experiments within this study revealed that the degradation of 
urea strongly impacts the pH of a shake flask culture without pH maintenance by ammonia 
generation. This leads to improved growth, but strongly reduced L-valine production. 
Furthermore, the analyses indicated an increased activity of the anaplerotic enzymes 
phosphoenolpyruvate- and pyruvate carboxylase under elevated levels of CO2/HCO3- 
(degradation product of urea) reducing the availability of the L-valine-precursor pyruvate by an 
enhanced efflux of glycolytic products via anaplerosis (chapter 3.3). The beneficial effect of urea 
deficiency on L-valine production, however, was more pronounced during shake flask cultivation 
(Fig. 5 and Fig. S4 in chapter 3.2 (Mahr et al., 2015)) – the method of choice during the 
performed evolution experiment. Obviously, the presence of urea in the CGXII minimal medium 
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provided a bottleneck for L-valine production. It remains a debatable point whether a similar 
urease inactivating mutation would have been found during altered cultivation and sorting 
conditions. Certainly, altered evolution strategies (e.g. sorting time, medium composition, etc.) 
may lead to completely different outcomes. The later application of the evolved strain has to be 
considered during the choice of cultivation conditions.  
4.2.2.3 Beyond biosensor-driven adaptive laboratory evolution 
Based on the natural mutation frequency, a total of seven mutations emerged during five rounds 
of biosensor-driven adaptive laboratory evolution (Tab. 2 in chapter 3.2, (Mahr et al., 2015)). 
Here, the implementation of a mutagenesis strategy, which only slightly increases the frequency 
of mutations, might be beneficial to allow selection from an increased genetic diversity. In 
contrast to random mutagenesis, the application of so-called mutator strains containing defective 
DNA repair systems might present an alternative option to increase diversity (Greener et al., 
1997; Loh et al., 2010; Luan et al., 2013; Muteeb and Sen, 2010). For example, Oide and 
colleagues observed the emergence of an unexpected high number of mutations during ALE, 
which was proposed to result from the spontaneous development of a mutator phenotype in C. 
glutamicum cells (Oide et al., 2015). Furthermore, Chou and Keasling established the feedback-
regulated evolution of phenotype (FREP) approach in E. coli, where the mutation rate is 
dynamically regulated by the target metabolite concentration controlling the expression of a 
mutator gene (mutD5) encoding a deficient proofreading exonuclease of DNA polymerase III 
(Chou and Keasling, 2013). However, FREP as well as the spontaneous development of mutator 
strains resulted in several hundred SNPs throughout the entire genome, which complicated the 
search for beneficial mutations. A strong reduction of the mutation rate by controlling a mutator 
gene from a weak, constitutive promoter might result in a decreased number of mutations and 
would allow interfacing with the biosensor-driven adaptive laboratory evolution approach. Here, 
a mutant mutT gene encoding oxoguanine-triphosphatase as part of the DNA mismatch repair 
machinery might be beneficial to increase the frequency of mutations in C. glutamicum 
(Nakamura et al., 2003; Resende et al., 2011).  
An alternative strategy to FACS-based laboratory evolution of inconspicuous phenotypes 
provides the coupling of the biosensor output to growth (Dietrich et al., 2013; van Sint Fiet et al., 
2006). By linking small-molecule production to an actuator mediating e.g. antibiotic or toxin 
resistance, for instance, bacterial growth in the presence of antibiotics or toxins is only possible, 
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if cells produce sufficient amounts of desired metabolites. Theoretically, a high selective pressure 
elicited by a high concentration of antibiotics or toxins should lead to the growth of cells with 
high metabolite production. One great limit of this strategy, however, is the evolution of 
antibiotic resistance not linked to product formation or the application of antibiotics, which are 
degraded over time. Furthermore, the system is limited at the point, where the detrimental effect 
of the antibiotic or toxin exceeds the potential for the development of resistance.  
Beyond that, biosensor-driven adaptive laboratory evolution can be highly beneficial to balance 
metabolic fluxes upon vast metabolic engineering efforts such as the introduction of heterologous 
biosynthetic pathways or the deletion of central physiological reactions. Moreover, this strategy 
may also be applied to improve the tolerance of the engineered strain to detrimental or growth-
inhibiting, inconspicuous end- and by-products such as aromatic amino acids (Polen et al., 2005). 
Altogether, biosensor-driven adaptive laboratory evolution approaches serve as excellent, 
complementary tools for metabolic engineering and may contribute to the identification of novel 
and non-intuitive targets to improve microbial cell factories. 
4.3 Future prospects of biosensor applications 
The present study demonstrates the enormous versatility of biosensors based on transcriptional 
regulators to reveal the formation of subpopulations in bioprocesses, to identify new and non-
intuitive targets for strain engineering, and to improve fluxes of metabolites or energy for 
increased product formation. The broad biotechnological application of biosensors requires 
readily accessible sensor devices with appropriate and/or easy adjustable performance 
characteristics. Although efforts exist to generate libraries of standardized biological modules – 
so-called BioBricks (http://parts.igem.org/Catalog) (Endy, 2005; Voigt, 2006), the design of 
suitable, orthogonal biosensors is not yet like a Lego set. The efficient, easy and fast generation 
of custom-made sensor devices is still a bottleneck of the biosensor technology and has to be 
addressed in the future.  
In the last years, increasing interest focused on the integration of regulatory circuits to 
dynamically control and balance metabolic fluxes upon diverse stimuli, and to overcome the 
natural barriers for metabolite overproduction (Dahl et al., 2013; Liu et al., 2015b; Xu et al., 
2014; Zhang et al., 2012; Zhou and Zeng, 2015). To this end, elaborated multiomic strategies are 
required to identify metabolic bottlenecks. In addition, efficient workflows are in demand to 
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screen for biological bricks suitable to dynamically control pathways. For example, toggle switch 
designs proved successful to shift between different metabolic pathways upon intrinsic or 
extrinsic signals (Anesiadis et al., 2013; Soma et al., 2014; Tsuruno et al., 2015): L-valine 
production in C. glutamicum was engineered by increasing the supply with precursors via the 
inactivation of the PDHC (ΔaceE) (Blombach et al., 2007; Schreiner et al., 2005) or the 
downregulation of aceE (Buchholz et al., 2013). However, both strategies are inefficient as they 
require the addition of two expensive carbon sources or feature an impaired growth phenotype 
with a low substrate-specific yield (Blombach et al., 2007; Buchholz et al., 2013; Eikmanns and 
Blombach, 2014). Here, the incorporation of a toggle switch redirecting the flux from glycolysis 
towards L-valine biosynthesis upon reaching a high biomass formation might kill two birds with 
one stone – increased growth rates and biomass formation as well as improved metabolite 
production on a single carbon source. Furthermore, genetic circuits might also be interesting to 
control and coordinate the performance of synthetic communities of orthogonal microbes where 
organism A delivers precursors, carbon sources or energy to organism B producing the 
metabolite of interest (Bertrand et al., 2014; Hoelzle et al., 2014; Jagmann and Philipp, 2014; 
Pandhal and Noirel, 2014). For instance, Marchand and Collins established a quorum-sensing 
based system to allow communication of a synthetic community of E. coli and B. subtilis 
(Marchand and Collins, 2013). Genetic circuits may be beneficial e.g. to elicit growth or 
biosynthetic pathways of organism B upon a sufficient production of precursors by organism A. 
In the last years, biosensors were designed that likewise report on by-product formation, 
accumulation of toxic intermediates or the lack of oxygen or carbon sources – extrinsic and 
intrinsic factors that can influence bioprocesses (Constantinou and Polizzi, 2013). Linking the 
biosensor signal via electrodes to feed pumps or the aeration system, for instance, the 
intracellular requirements obscured by extracellular measurements may immediately be satisfied.  
All these examples demonstrate the high potential of genetically-encoded biosensors to give new 
impetus to biotechnological strain and bioprocess development. Driven by the fascination and 
potential of microbial cells, the creativity for the implementation of biosensor circuits in 
microbial cell factories will certainly not arrest in the future.  
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6.2 Supplemental information – Biosensor-driven adaptive laboratory evolution of L-
valine production in Corynebacterium glutamicum 
 
Regina Mahr1, Cornelia Gätgens1, Jochem Gätgens1, Tino Polen1, Jörn Kalinowski2 and Julia 
Frunzke1* 
 
Supporting Tables 
Table S1 Comparative transcriptome analysis of mRNA levels of populations after the third 
versus after the second evolution step. Listed are all genes showing a ≥2-fold altered mRNA 
level. The relative mRNA level is given as average ratio (3rd/2nd) calculated from three 
independent biological replicates. Known transcriptional regulation of genes by transcriptional 
regulators is indicated by R (repression) and A (activation) (Pauling et al., 2012). 
Locus Gene Annotation R/A Ratio 
3rd/2nd 
p value 
      
  GlxR regulon    
cg0344 fabG1 3-oxoacyl-acyl-carrier protein reductase  RGlxR 2.937 0.043 
cg0345 - putative metal-dependent hydrolase of the 
TIM-barrel fold 
RGlxR 2.488 0.002 
cg0346 fadE glutaryl-CoA dehydrogenase  RGlxR 2.415 0.045 
cg0445 sdhCD succinate:menaquinone oxidoreductase, 
cytochrome b subunit 
RGlxR 
RRamB 
RRipA 
ADtxR 
ARamA 
0.459 0.036 
cg0791 pyc pyruvate carboxylase  RGlxR 
RRamB 
0.405 0.049 
cg0797 prpB1 2-methylisocitrate lyase RGlxR 0.355 0.011 
cg0812 dtsR1 acetyl/propionyl-CoA carboxylase, beta 
subunit 
RGlxR 
RFasR 
0.308 0.006 
cg0936 rpf1 resuscitation promoting factor AGlxR 0.267 0.011 
cg0957 fas-IB fatty acid synthase, Fas-I type RGlxR 
RFasR 
0.401 0.024 
cg1037 rpf2 resuscitation promoting factor, secreted 
protein 
AGlxR 
ARamA 
RRamB 
RMtrA 
0.347 0.035 
cg1314 putP proline transport system RGlxR 
ALexA 
0.413 <0.001 
cg1341 narI nitrate reductase, gamma subunit AGlxR 
ARosR 
0.223 0.033 
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Locus Gene Annotation R/A Ratio 
3rd/2nd 
p value 
RRipA 
RArnR 
cg1342 narJ nitrate reductase, delta subunit, assembly 
factor 
AGlxR 
ARosR 
RRipA 
RArnR 
0.206 0.039 
cg1343 narH nitrate reductase, beta subunit, iron sulfur 
protein 
AGlxR 
ARosR 
RRipA 
RArnR 
0.315 0.010 
cg1344 narG nitrate reductase, alpha subunit AGlxR 
ARosR 
RRipA 
RArnR 
0.271 0.032 
cg2119 pfkB 1-phosphofructokinase  RGlxR 
RSugR 
RFruR 
RLldR 
0.471 <0.001 
cg2403 qcrB cytochrome bc1 complex, cytochrome b 
subunit 
AGlxR 
AHrrA 
0.416 <0.001 
cg2404 qcrA cytochrome bc1 complex, Rieske iron-sulfur 
protein 
AGlxR 
AHrrA 
0.385 <0.001 
cg2406 ctaE cytochrome aa3 oxidase, subunit 3 AGlxR 
AHrrA 
RRamB 
0.467 <0.001 
cg2559 aceB malate synthase, part of glyoxylate shunt RGlxR 
RRamB 
ARamA 
ACspA2 
0.373 0.047 
cg2840 actA coenzyme A transferase acetate, propionate, 
succinate  
AGlxR 
RRamB 
0.427 0.009 
      
  ArgR regulon    
cg1580 argC N-acetyl-gamma-glutamyl-phosphate 
reductase  
RArgR 
RFarR 
0.144 0.007 
cg1582 argB acetylglutamate kinase  RArgR 
RFarR 
0.345 0.003 
cg1583 argD acetylornithine aminotransferase  RArgR 
RFarR 
0.291 0.011 
cg1584 argF ornithine carbamoyltransferase RArgR 
RFarR 
0.347 <0.001 
cg1585 argR transcriptional repressor of arginine 
biosynthesis, ArgR-family 
RArgR 
RFarR 
0.410 0.001 
cg1588 argH argininosuccinate lyase  RArgR 0.453 <0.001 
cg1814 carA carbamoyl-phosphate synthase, small subunit  RArgR 0.383 0.005 
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Locus Gene Annotation R/A Ratio 
3rd/2nd 
p value 
      
  ArsR regulon    
cg1705 arsB1 arsenite permease, arsenical resistance-3 
ACR3 family 
RArsR1 
RArsR2 
2.980 0.044 
cg1706 arsC1 arsenate reductase, arsenical pump modifier  RArsR1 
RArsR2 
2.555 0.018 
  
 
   
  SufR regulon    
cg1760 sufU cysteine desulfhydrase RSufR 
ROxyR 
ASigM 
ASigH 
3.175 0.032 
cg1762 sufC Fe-S cluster assembly ATPase RSufR 
ROxyR 
ASigM 
ASigH 
4.121 0.020 
cg1763 sufD Fe-S cluster assembly membrane protein RSufR 
ROxyR 
ASigM 
ASigH 
4.910 0.013 
cg1764 sufB Fe-S cluster assembly protein RSufR 
ROxyR 
ASigM 
ASigH 
5.956 0.016 
cg1765 sufR transcriptional regulator of suf operon RSufR 
ROxyR 
ASigM 
ASigH 
7.239 0.011 
      
  Further interesting targets    
cg3149
* 
alaT aminotransferase, uses alanine, glutamate, 2-
aminobutyrate and aspartate 
 0.660 0.089 
cg2877
* 
avtA aminotransferase, uses alanine, keto-
isovalerate and ketobutyrate 
 0.801 0.059 
      
  SOS and stress response    
cg0831 tusG trehalose uptake system, ABC-type, permease   0.379 0.005 
cg0834 tusE trehalose uptake system, ABC-type, bacterial 
extracellular solute-binding protein 
ALexA 0.353 0.024 
cg0892 - hypothetical protein  0.408 0.045 
cg1362 atpB F1FO-ATP synthase, -subunit of FO part ASigH 0.311 0.001 
cg1364 atpF F1FO-ATP synthase, -subunit of FO part ASigH 0.320 0.008 
cg1553 qor2 quinone oxidoreductase RQorR 
RHrcA 
2.959 0.031 
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Locus Gene Annotation R/A Ratio 
3rd/2nd 
p value 
cg2106 - hypothetical protein, conserved ASigH 2.846 0.042 
cg3011 groEL chaperonin GroEL ASigH 
RHrcA 
RHspR 
2.538 0.004 
cg3327 dps starvation-induced DNA protecting protein ADtxR 
ROxyR 
2.220 <0.001 
cg3330 - putative secreted protein ASigB 3.147 0.012 
      
  Others    
cg0061 rodA putative FTSW/RODA/SPOVE family cell 
cycle protein 
 0.442 0.030 
cg0177 - hypothetical protein  0.443 0.021 
cg0233  hypothetical protein, conserved  0.390 0.007 
cg0238 - putative L-gulonolactone oxidase, FAD/FMN-
containing dehydrogenase  
 0.426 <0.001 
cg0258 moaE molybdopterin cofactor synthase, large 
subunit 2 
 0.476 0.013 
cg0435 udgA1 UDP-glucose 6-dehydrogenase   0.445 <0.001 
cg0593 rpsJ 30S ribosomal protein S10  2.373 0.009 
cg0699 guaB2 inositol-5-monophosphate dehydrogenase  ASigH 0.417 0.009 
cg1076 glmU putative UDP-N-acetylglucosamine 
pyrophosphorylase  
 0.447 0.019 
cg1138 - putative phosphinothricin acetyltransferase  0.417 0.005 
cg1203 - putative Mg2+ chelatase subunit ChlI  0.412 <0.001 
cg1333 argS arginyl-tRNA synthetase   0.425 0.001 
cg1479 malP maltodextrin phosphorylase  0.298 0.005 
cg1730 - putative secreted protease subunit, 
stomatin/prohibitin homolog 
 0.403 0.020 
cg1793 - hypothetical protein, conserved  0.412 0.008 
cg1832  putative ABC-type iron-siderophore 
transporter, substrate-binding lipoprotein 
RCg1831 0.425 0.050 
cg1842 - putative secreted metalloprotease  0.427 0.034 
cg1905 - hypothetical protein CGP3 region  0.314 0.018 
cg2160 - putative hydrolase of metallo-beta-lactamase 
superfamily 
 0.468 <0.001 
cg2523 malQ 4-alpha-glucanotransferase   0.403 <0.001 
cg2704 - putative ABC-type putative sugar transporter, 
permease subunit 
 0.376 <0.001 
cg2857 purF amidophosphoribosyltransferase  0.395 0.001 
cg3117 cysX ferredoxin-like protein ACysR 
RDtxR 
RMcbR 
0.462 0.002 
cg3179 fadD2 acyl-CoA synthase   0.459 0.002 
cg3303 - putative transcriptional regulator, PadR-like   2.336 0.003 
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Supporting Figures 
 
 
Fig. S1 The increased fluorescent output of evolved C. glutamicum ΔaceE strains does not derive 
from mutations within the sensor plasmids. Sensor plasmids (E1-E5) were isolated from evolved 
C. glutamicum ΔaceE strains (black) and were reintroduced into the non-evolved parental strain 
C. glutamicum ΔaceE (white). The specific eYFP fluorescent output of evolved strains and the 
non-evolved ΔaceE strains (containing the sensor of evolved strains) was recorded after 30 hours 
of cultivation in microtiter plates. The data represent average values from three independent 
cultivations including standard deviation. 
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Fig. S2 Growth (filled symbols) and L-valine production (empty symbols) of C. glutamicum 
ΔaceE (black) and the evolved strains M1 (red) and M2 (blue) (Fig. 3, Tab. 2) during shake flask 
cultivation. First, cells were inoculated in 4 ml BHI medium containing 51 mM acetate and 
kanamycin (50 µg/ml), and incubated for eight hours at 30°C. Then, 1 ml of the preculture was 
used to inoculate a second preculture in 20 ml CGXII minimal medium containing 222 mM 
glucose, 254 mM acetate and kanamycin (50 µg/ml). After an overnight cultivation at 30°C, cells 
were inoculated to an OD600 of 1 in 50 ml CGXII minimal medium containing 222 mM glucose, 
254 mM acetate and kanamycin (50 µg/ml). 
 
 
Fig. S3 GC-ToF-MS analysis of the influence of urea on the intracellular metabolite pool of C. 
glutamicum ΔaceE in comparison to ΔaceE ureD-E188* (Fig. 5). Peak areas of MS spectra are 
plotted against each other. The solid line marks the 45 degree angle line. Abbreviations: alanine 
(a), 2-aceto-lactate (ac), dihydroxyisovalerate (d), lactate (l), pyruvate (p), urea (u), valine (v). 
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Saturated peak areas are marked with an asterisk (*), while the plus (+) indicates the sum of peak 
areas of different trimethylsilyl (TMS) derivatives (L-valine 1TMS and L-valine 2TMS; L-
alanine 2TMS and L-alanine 3TMS). 
 
 
 
Fig. S4 Bioreactor batch fermentation of C. glutamicum ΔaceE in presence (♦) and without urea 
(■), and C. glutamicum ΔaceE ureD-E188* in presence (●) and without urea (×). Growth and L-
valine production were monitored for 45 hours. Fermentations were performed at 30°C in a 1.4 L 
glass bioreactor (Multifors Multi-Fermenter System) with independently controllable bioreactors 
(Infors, Einsbach, Germany). Cells of a 50 ml overnight pre-culture in BHI medium containing 
85 mM acetate were harvested, washed with 0.9% (w/v) saline and then inoculated to an OD600 of 
1.5 in 500 ml CGXII minimal medium containing 0.5% BHI, 254 mM acetate and 222 mM 
glucose. The bioreactors were sparged with 0.9 l min-1 synthetic air, while dissolved oxygen was 
measured using a polarimetric oxygen electrode (Mettler Toledo, Gießen, Germany). The 
dissolved oxygen concentration was adjusted to 30% by a stirrer speed cascade from 600 to 
1000 rpm. The pH was adjusted to pH 7 using 3 M potassium hydroxide and 3 M hydrochloric 
acid, while online pH measurements were done using a standard pH electrode (Mettler Toledo, 
Gießen, Germany). Foam development was suppressed by titration of 25% (v/v) silicon antifoam 
204/water suspension (Sigma Aldrich, Steinheim, Germany).  
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6.3 Supplemental information – Urease inactivity increases L-valine production in 
Corynebacterium glutamicum 
Supporting Tables 
Table S1 Comparative transcriptome analysis of mRNA levels of C. glutamicum ΔaceE and 
ΔaceE ureD-E188* after 28 hours of shake flask cultivation in CGXII minimal medium 
containing 222 mM glucose and 254 mM acetate. Listed are all genes showing a ≥1.5-fold altered 
mRNA level and a p value of ≤0.20, with the exception of some interesting genes. The relative 
mRNA level is given as average ratio (ΔaceE ureD-E188*/ΔaceE) cultivated from three 
independent biological replicates.  
Locus Gene Annotation Ratio ΔaceE ureD-
E188*/ΔaceE 
p value 
 
 GlxR regulon   
cg0566 gabT 4-aminobutyrate aminotransferase 2.13 0.195 
cg0791 pyc pyruvate carboxylase 0.17 0.281 
cg0797 prpB1 2-methylisocitrate lyase 2.09 0.143 
cg1143 - putative transcriptional regulator 1.72 0.095 
cg2403 qcrB cytochrome bc1 complex, cytochrome b 
subunit 
0.28 0.255 
cg2410 ltsA glutamine-dependent amidotransferase  1.67 0.001 
cg2831 ramA transcriptional regulator, acetate 
metabolism 
0.20 0.299 
cg3216 gntP gluconate permease, gluconate:H+ 
symporter GntP family 
2.20 0.055 
cg3219 ldhA  NAD-dependent L-lactate dehydrogenase 0.24 0.300 
cg3227 lldD menaquinone-dependent L-lactate 
dehydrogenase  
0.26 0.291 
     
  AmtR regulon   
cg0115 ureC urease alpha subunit 0.34 0.310 
cg1064 urtC ABC-type urea uptake system, permease 
subunit 
1.60 0.200 
cg1781 soxA sarcosine oxidase- C-terminal fragment 1.66 0.002 
  
 
  
  SOS and stress response   
cg0617 - putative molybdopterin-guanine 
dinucleotide biosynthesis protein 
0.37 0.160 
cg1319 - putative ATPase involved in DNA repair 1.58 0.070 
cg1362 atpB F1FO-ATP synthase, a-subunit of FO part 1.63 0.001 
cg1363 atpE F1FO-ATP synthase, c-subunit of FO part 0.34 0.324 
cg1367 atpG F1FO-ATP synthase, γ-subunit of F1 part 0.19 0.287 
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Locus Gene Annotation Ratio ΔaceE ureD-
E188*/ΔaceE 
p value 
cg1696 - putative antibiotic efflux permease of the 
major facilitator superfamily 
9.00 0.167 
cg1708 - hypothetical protein, conserved 2.98 0.067 
cg1765 sufR transcriptional regulator of suf operon 0.24 0.142 
cg2644 clpP2 ATP-dependent Clp protease proteolytic 
subunit  
0.18 0.292 
     
  RipA/DtxR regulon   
cg0310 katA catalase  0.61 0.382 
     
cg0445 sdhC  succinate:menaquinone oxidoreductase, 
cytochrome b subunit 
0.69 0.498 
     
cg0768 - putative iron-siderophore ABC transporter 2.15 0.187 
cg0769 - putative iron-siderophore ABC transporter 2.87 0.152 
cg1345 narK nitrate/nitrite antiporter 0.39 0.311 
     
  Specific biosynthesis pathways   
cg0977 - putative ABC-type transport system 0.50 0.001 
cg1218 ndnR transcriptional repressor of NAD de novo 
biosynthesis genes  
2.07 0.059 
cg1588 argH argininosuccinate lyase 0.07 0.224 
cg2269 - putative permease 1.78 0.153 
cg2789 mrx2 mycoredoxin 2 0.44 0.248 
cg3359 trpE anthranilate synthase component I  0.17 0.343 
     
  TCA   
cg2425 sucE succinate exporter 1.54 0.063 
cg0445 sdhC  succinate:menaquinone oxidoreductase, 
cytochrome b subunit 
0.69 0.498 
cg2613 mdh malate dehydrogenase (EC:1.1.1.37) 0.58 0.393 
     
  Others   
cg0074 - putative sulfurtransferase 1.73 0.050 
cg0181 alkB alkylated DNA repair protein 1.63 0.077 
cg0183 - putative lyse type translocator 1.52 0.070 
cg0208 - hypothetical protein 0.14 0.169 
cg0248 - putative ABC-type polysaccharide/polyol 
phosphate export sytem 
1.56 0.021 
cg0356 - putative serine protease 1.50 0.152 
cg0368 - putative secreted protein, conserved  1.88 0.145 
cg0369 - putative secreted protein, conserved  1.57 0.045 
cg0385 bglS' beta-glucosidase precursor-N-terminal 
domain 
1.62 0.155 
cg0401 rmlA1 TDP-glucose pyrophosphorylase 1.55 0.159 
cg0525 - hypothetical protein 3.07 0.174 
cg0640 fdxB ferredoxin no. 2, 2Fe-2S 1.64 0.138 
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Locus Gene Annotation Ratio ΔaceE ureD-
E188*/ΔaceE 
p value 
cg0658 rptA terminal rhamnopyranosyltransferase 1.72 0.096 
cg0672 - hypothetical protein, conserved 1.95 0.080 
cg0733 - putative ABC transporter ATP-binding 
protein 
1.78 0.087 
cg0752 - putative secreted or membrane protein 0.25 0.140 
cg0765 - putative secreted protein 2.05 0.130 
cg0784 - putative cell wall-associated hydrolase 1.69 0.050 
cg0794 yciC putative P-loop GTPase  2.03 0.046 
cg0852 - hypothetical protein, conserved 1.51 0.033 
cg0866 - putative purine/pyrimidine phosphoribosyl 
transferase 
1.64 0.070 
cg0872 - putative GTPase 0.40 0.199 
cg0919 tnp18a transposase 1.67 0.001 
cg0973 pgi glucose-6-phosphate isomerase  0.28 0.274 
cg1111 eno enolase, phosphopyruvate hydratase 0.26 0.260 
cg1118 - putative pyrimidine reductase 1.59 0.001 
cg1133 glyA serine hydroxymethyltransferase  0.33 0.198 
cg1149 - hypothetical protein  1.58 0.135 
cg1236 tpx thiol peroxidase  0.03 0.088 
cg1302 - putative HKD family nuclease 1.58 0.165 
cg1354 rho transcription termination factor Rho 1.86 0.005 
cg1355 prfA peptide chain release factor 1 RF-1 2.11 0.059 
cg1360 - putative membrane protein 1.95 0.025 
cg1413 rbsB ribose/xylose transport 0.04 0.263 
cg1457 dnaQ2 putative DNA polymerase III, epsilon 
subunit  
1.59 0.124 
cg1467 - putative transcriptional regulator 1.69 0.119 
cg1501 coaD phosphopantetheine adenylyltransferase  1.63 0.085 
cg1754 - hypothetical protein 1.77 0.088 
cg1807 dfp phosphopantothenoylcysteine 
synthase/decarboxylase 
1.71 0.146 
cg1827 aroB 3-dehydroquinate synthase  1.61 0.073 
cg1829 aroC chorismate synthase  2.01 0.084 
cg1922 - hypothetical protein CGP3 region 2.10 0.109 
cg1950 tnp14b transposase  fragment CGP3 region 1.60 0.018 
cg1978 - hypothetical protein CGP3 region 1.54 0.067 
cg1984 - hypothetical protein CGP3 region 2.03 0.079 
cg1993 - hypothetical protein CGP3 region 1.94 0.145 
cg2072 - putative di-and tricarboxylate transporter 1.55 0.075 
cg2088 - hypothetical protein 1.53 0.003 
cg2092 sigA RNA polymerase sigma factor 0.37 0.320 
cg2102 sigB RNA polymerase sigma factor 0.23 0.315 
cg2104 galE UDP-glucose 4-epimerase 0.20 0.314 
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Locus Gene Annotation Ratio ΔaceE ureD-
E188*/ΔaceE 
p value 
cg2340 - putative ABC-type amino acid transport 
system 
1.67 0.001 
cg2382 - putative GCN5-related N-acetyltransferase 1.62 0.037 
cg2389 - putative membrane protein 1.57 0.101 
cg2446 glnE glutamate-ammonia-ligase 
adenylyltransferase 
0.74 0.182 
cg2483 - hypothetical protein 1.98 0.101 
cg2490 - putative secreted guanine-specific 
ribonuclease 
1.77 0.029 
cg2494 dgt deoxyguanosinetriphosphate 
triphosphohydrolase-like protein 
1.55 0.009 
cg2568 dctM C4-dicarboxylate transport system 
permease large protein 
6.58 0.177 
cg2574 - putative threonine efflux transporter 1.51 0.075 
cg2673 - putative permease of the major facilitator 
superfamily 
1.63 0.035 
cg2757 tnp15a transposase 1.67 0.021 
cg2772 clpS ATP-dependent Clp protease adaptor 
protein 
0.46 0.312 
cg2797 - hypothetical protein, conserved 2.26 0.121 
cg2799 pknE putative secreted protein 0.37 0.201 
cg2868 nuc putative extracellular nuclease 1.95 0.064 
cg2888 phoR two component response regulator 0.08 0.185 
cg2900 ddh meso-diaminopimelate dehydrogenase  1.70 0.023 
cg2918 - putative dehydrogenase or related protein 1.94 0.157 
cg2919 - putative oxidoreductase 1.54 0.015 
cg2940 - putative ATPase components of ABC-type 
transport system 
1.97 0.133 
cg3016 - hypothetical protein 2.03 0.083 
cg3049 fprA putative ferredoxin/ferredoxin-NADP 
reductase  
0.24 0.293 
cg3060 cgtS6 two component sensor kinase 2.11 0.086 
cg3065 - hypothetical protein, conserved 1.56 0.168 
cg3146 bglY' beta-glucosidase-fragment 1.51 0.057 
cg3148 'fepC' putative ABC transporter 1.57 0.129 
cg3185 - hypothetical protein, conserved 1.53 0.161 
cg3199 - putative hydrolase of the HAD superfamily 1.61 0.195 
cg3231 - hypothetical protein 1.77 0.162 
cg3284 copS two component sensor kinase 1.51 0.050 
cg3349 nagL maleylpyruvate isomerase 3.21 0.186 
cgr10 - 5S ribosomal RNA 1.54 0.106 
cgtRNA_
3542 
- Tyr tRNA 1.55 0.164 
cgtRNA_
3570 
- Met tRNA 1.52 0.020 
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Fig. S1 GC-ToF-MS analysis of the supernatant after cultivating C. glutamicum ΔaceE with and 
without urea and ΔaceE ureD-E188* with urea for 30 hours. A. Overview of MS spectra. B. MS 
spectra of succinate and 2-acetolactate. The red arrow indicates the reading direction (succinate 
and 2-acetolactate peaks are comparable among themselves, but not both molecules with each 
other). Metabolome analyses of supernatants were performed on a 6890N gas chromatograph 
(Agilent, Santa Clara, USA) coupled to a Micromass GCT Premier high-resolution time-of-flight 
mass spectrometer (Waters, Milford, USA). Sample preparation, derivatization, MS operation 
and peak identification were performed as described previously (Paczia et al., 2012). 
Abbreviation: trimethylsilyl (TMS) derivatives.  
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6.4 Supplemental information – Screening of an Escherichia coli promoter library for a 
phenylalanine biosensor 
Supporting Figures 
 
Fig. S1 Screening of galactose and L-phenylalanine responsive promoters. a Initially, the pooled strains 
containing of the Alon promoter library were incubated in 20 ml M9 minimal medium without effector 
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molecules and split in fractions of low and high fluorescence to reduce the fraction of constitutively active 
or inactive promoters (not shown). Subsequently, cells with low fluorescence were re-incubated in 20 ml 
M9 minimal medium containing 0.5% (w/v) of the effector molecule galactose for six hours at 37°C and 
120 rpm. One million cells from the green gate were sorted on filter plates and incubated overnight at 
37°C and 170 rpm in 4 ml LB with kanamycin. To separate constitutive “ON” promoters from responsive 
promoters, counter-selection was performed by subsequently incubating the isolated cells in 20 ml M9 
minimal medium containing 0.5% (w/v) glucose for six hours. This time, cells from the red gate (“OFF” 
promoters) were sorted on filter plates and incubated overnight in 4 ml LB with kanamycin. To reduce the 
fraction of false positive clones, one further round of toggled screening was performed. The green and red 
arrows indicate the gate chosen for cell sorting throughout the screening procedure. A culture grown in 
glucose minimal medium served as reference. The numbers indicate the percentage of the entire 
population covered by the respective gate. b Biomass formation and specific GFPmut2 fluorescence of E. 
coli K-12 MG1655 containing plasmids pUA66 (♦), pUA66_PgalS-gfpmut2 (●) and pUA66_PlacZ-gfpmut2 
(■). The strains were cultivated in the BioLector microbioreactor system at 37°C and 1200 rpm in M9 
minimal medium containing 0.5% (w/v) glucose as negative control (filled symbols) or 0.5% (w/v) 
galactose as inductor (empty symbols). c Specific Venus fluorescence of selected clones from the Alon 
library containing promoter-gfpmut2 fusions that were enriched during the screening for L-phenylalanine 
responsive promoters. Cells were cultivated in the presence (black bar) or without (gray bar) 3 mM L-
alanyl-L-phenylalanine (Ala-Phe). Numbers above bars indicate the minimal dynamic range (fold-change 
induced versus non-induced). b and c Data represent average values of three independent biological 
replicates.  
 
 
Fig. S2 Flow cytometric (FC) analyses of different biosensor designs a type two, b type four and c type 
three in presence of different ratios of Ala-Ala and Ala-Phe (overall concentration 3 mM) showing 
histograms of the Venus fluorescence. Cells were cultivated in microtiter plates in M9 minimal medium 
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containing 0.5% (w/v) glucose and kanamycin in the presence of different Ala-Phe/Ala-Ala ratios. After 
seven hours of incubation, the sensor output was analyzed by FC.  
 
 
 
 
Fig. S3 Growth and specific Venus fluorescence of isolated mutants. a and b 90 isolated mutants (each 45 
mutants depicted in a and b) were analyzed by cultivation at microtiter scale in phenylalanine production 
medium containing 0.5% (w/v) glucose and kanamycin for 28 hours (colored lines). Growth and 
fluorescence of the non-mutagenized E. coli K-12 MG1655/pJC1-mtr sensor-type1 strain is indicated by 
the black line. Data shown for isolated mutant clones represent single measurements; the data shown for 
the non-mutagenized wild type-strain represent average data of three biological replicates.  
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Fig. S4 Biosensor-based single-cell analysis reveals cell-to-cell variability of E. coli K-12 MG1655. a FC 
analysis of E. coli K-12 MG1655 pJC1-mtr sensor-type1 cells after eight hours of cultivation in 20 ml 
phenylalanine production medium containing 0.5% (w/v) glucose and kanamycin at 37°C and 120 rpm. 
Dot plots display the side scatter (SSC), forward scatter (FSC) and Venus fluorescence of single cells. 2 x 
105 cells were sorted from gate P1 (red) and P2 (green) in 4 ml LB with kanamycin and incubated 
overnight at 37°C and 170 rpm. The following day, cells were inoculated in 20 ml phenylalanine 
production medium, incubated for eight hours and re-analyzed by FC (P1, red and P2, green). The 
numbers in the gates indicate the percentage of cells showing spontaneously increased fluorescent outputs. 
b Live cell imaging of isogenic microcolonies of E. coli K-12 MG1655 cells containing the sensor 
plasmid pJC1-mtr sensor-type1 in presence of 3 mM (upper row) and without (lower row) the dipeptide L-
alanyl-L-phenylalanine (Ala-Phe). The cells were cultivated for eight hours in L-phenylalanine production 
medium in microfluidic monolayer cultivation chambers as previously described (Grünberger et al., 2012; 
Grünberger et al., 2015). (Grünberger et al., 2012; Grünberger et al., 2015). 
Appendix Screening of a promoter library for a phenylalanine biosensor 159 
 
Supporting references 
Grünberger, A., Paczia, N., Probst, C., Schendzielorz, G., Eggeling, L., Noack, S., Wiechert, W., 
Kohlheyer, D., 2012. A disposable picolitre bioreactor for cultivation and investigation of 
industrially relevant bacteria on the single cell level. Lab Chip. 12, 2060-8. 
Grünberger, A., Probst, C., Helfrich, S., Nanda, A., Stute, B., Wiechert, W., von Lieres, E., Nöh, 
K., Frunzke, J., Kohlheyer, D., 2015. Spatiotemporal microbial single-cell analysis using a high-
throughput microfluidics cultivation platform. Cytometry A. 87, 1101-15. 
 
160 Discussion Appendix 
6.5 Supplemental information – Discussion 
Supporting Tables 
Table S4.2.1: Overview of mutations identified in five mutants (1-5) isolated by FACS HT 
screening of an MNNG-mutagenized E. coli K-12 MG1655 library using the mtr biosensor 
encoded on the plasmid pJC1-mtr biosensor type1. Sequencing and comparative analysis were 
performed as previously described (Mahr et al., 2015). Reads were mapped using accession 
NC_000913 as the reference genome. Mutations in genes associated with the biosynthesis or 
transport of aromatic amino acids are highlighted with an asterisk. Abbreviation: Original strain 
E. coli K-12 MG1655 pJC1-mtr biosensor type1 (parental strain).  
 
Gene Gene 
name 
Mutein Parental 
strain 
Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
b0040 caiT A203V - x - - - - 
b0043 fixC G316S - x - - - - 
b0068 thiB T160I - x - - - - 
b0073 leuB A270V - x - - - - 
b0084 ftsI V453I - - - - x - 
b0085 murE G378D - x - - - - 
b0088 murD A109T - x - - - - 
b0219 yafV A82T - - - - x - 
b0463 acrA A355T - - - - x - 
b0532 sfmD A388V - - - - x - 
b0621 dcuC D100N - - - - x - 
b0841 ybjG R139C - - - - - x 
b0844 ybjI P56S - - - - - x 
b0847 ybjL A428V - - - - - x 
b0847 ybjL L298F - - - - - x 
b0876 ybjD P332S - - - x - - 
b0974 hyaC T216I - - - - - x 
b0984 gfcD G264D - - - - - x 
b0997 torA R592H - - - - - x 
b0998 torD A96T - - - - - x 
b0999 cbpM G29D - - - - - x 
b1018 efeO E80K - - - - - x 
b1022 pgaC R293C - - - - - x 
b1023 pgaB P126S - - - - - x 
b1159 mcrA P249S - - x - - - 
b1177 ycgJ G15R - x - - - - 
b1180 ycgM E86K - x - - - - 
b1184 umuC A178T - x - - - - 
b1192 ldcA S232N - - - x - - 
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Gene Gene 
name 
Mutein Parental 
strain 
Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
b1194 ycgR A170T - - - x - - 
b1194 ycgR S2N - - - x - - 
b1195 ymgE M21I - x - - - - 
b1198 dhaM G103D - - - x - - 
b1201 dhaR G111E - x - - - - 
b1201 dhaR A122T - x - - - - 
b1202 ycgV P653L - x - - - - 
b1207 prs G294D - - - x - - 
b1220 ychO P280S - - - x - - 
b1224 narG H706R - - - x - - 
b1224 narG T791I - - - x - - 
b1247 oppF G85D - x - - - - 
b1255 yciC G38R - - x - - - 
b1261 trpB* R363H - - - x - - 
b1261 trpB* E155K - - - x - - 
b1263 trpD* A130T - - - x - - 
b1264 trpE* C377Y - - x - - - 
b1276 acnA V766M - - x - - - 
b1315 ycjS D301N - - x - - - 
b1320 ycjW T88I - - x - - - 
b1372 stfR G859E - - x - - - 
b1378 pfo A920V - - x - - - 
b1386 tynA T717I - - x - - - 
b1387 paaZ H525Y - - x - - - 
b1392 paaE V72M - - x - - - 
b1394 paaG L209F - - - - x - 
b1397 paaJ E219K - - x - - - 
b1407 ydbD G396D - - x - - - 
b1407 ydbD A531T - - x - - - 
b1407 ydbD A697T - - x - - - 
b1411 ynbD W235* - - x - - - 
b1411 ynbD W236* - - x - - - 
b1413 hrpA A347T - - x - - - 
b1421 trg G295D - - x - - - 
b1431 ydcL G188D - - x - - - 
b1450 mcbR E76K - - x - - - 
b1459 yncI G197D - - x - - - 
b1463 nhoA W119* - - x - - - 
b1464 yddE P150S - - x - - - 
b1468 narZ P90S - - x - - - 
b1483 ddpF P265S - - x - - - 
b1486 ddpB A107V - - x - - - 
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Gene Gene 
name 
Mutein Parental 
strain 
Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
b1487 ddpA A297V - - x - - - 
b1487 ddpA T96S - - - - x - 
b1492 gadC P481S - - x - - - 
b1493 gadB P191S - - x - - - 
b1501 ydeP P564L - - x - - - 
b1612 fumA P5S - - - - x - 
b1623 add A201V - - - x - - 
b1711 btuC G153E - - - x - - 
b1750 ydjX L12F - - - x - - 
b1753 ynjA A120V - - - x - - 
b1754 ynjB S264L - - - x - - 
b1764 selD G181E - - - x - - 
b1774 ydjJ G148R - - - x - - 
b1790 yeaM A239T - - - x - - 
b1808 yoaA A62T - - - x - - 
b1808 yoaA P7L - - x - - - 
b1809 yoaB P90S - - - x - - 
b1833 yebS S119L - - - x - - 
b1849 purT R68H - - - - x - 
b1864 yebC T174I - - x - - - 
b1864 yebC T126I - - x - - - 
b1868 yecE G128D - - x - - - 
b1876 argS G297D - - - - - x 
b1876 argS V574I - - x - - - 
b1886 tar P539S - - - - - x 
b1896 otsA Q444* - - x - - - 
b1907 tyrP* D280N - - x - - - 
b1916 sdiA V211I - - - - - x 
b1919 dcyD A143V - - x - - - 
b1924 fliD G8R - - x - - - 
b1929 yedE V21I - - x - - - 
b1938 fliF G101D - - x - - - 
b1943 fliK D142G - - x - - - 
b1952 dsrB A23T - - x - - - 
b1957 yodC V11I - - x - - - 
b1959 yedA* A303V - - x - - - 
b1967 hchA S34F - - x - - - 
b1976 mtfA P232L - - x - - - 
b1978 yeeJ V1431I - - - - - x 
b1988 nac G170E - - x - - - 
b1992 cobS G228S - - x - - - 
b2000 flu T87I - - x - - - 
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Gene Gene 
name 
Mutein Parental 
strain 
Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
b2000 flu G484S - - - - - x 
b2000 flu G751D - - - - - x 
b2000 flu G826S - - - - - x 
b2006 yeeW D15N - - - - - x 
b2025 hisF D182N - - - - - x 
b2042 wcaN P202S - - x - - - 
b2043 wcaM R278C - - - - - x 
b2046 wzxC P167S - - - - - x 
b2049 cpsB A407V - - - - - x 
b2049 cpsB S282F - - - - - x 
b2064 asmA Q384* - - - - - x 
b2069 yegD G272D - - x - - - 
b2071 yegJ D114N - - x - - - 
b2076 mdtC G251D - - - - - x 
b2078 baeS G59S - - - - - x 
b2078 baeS G137D - - x - - - 
b2079 baeR R51H - - - - - x 
b2086 yegS D244N - - - - - x 
b2091 gatD R304W - - x - - - 
b2095 gatZ A413V - - - - - x 
b2095 gatZ A32T - - - - - x 
b2096 gatY G139D - - - - - x 
b2097 fbaB P24S - - x - - - 
b2100 yegV G53D - - x - - - 
b2100 yegV A62T - - x - - - 
b2103 thiD R197W - - - - - x 
b2124 yehS A77V - - x - - - 
b2131 osmF A8V - - x - - - 
b2132 bglX R486C - - - - - x 
b2134 pbpG R274C - - - - - x 
b2134 pbpG R104C - - x - - - 
b2139 mdtQ P359L - - - - - x 
b2139 mdtQ P141S - - x - - - 
b2142 yohK V160I - - x - - - 
b2144 sanA E228K - - x - - - 
b2146 preT E295K - - x - - - 
b2151 galS P291L - - x - - - 
b2151 galS P47S - - - - - x 
b2154 yeiG D92N - - x - - - 
b2158 yeiH D130N - - - - - x 
b2159 nfo V174I - - - - - x 
b2163 yeiL V85M - - x - - - 
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Gene Gene 
name 
Mutein Parental 
strain 
Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
b2176 rtn P326S - - x - - - 
b2176 rtn G494D - - x - - - 
b2178 yejB S351N - - - - - x 
b2180 yejF E503K - - - - - x 
b2206 napA S618S - - x - - - 
b2206 napA T297M - - x - - - 
b2214 apbE A192V - - - - - x 
b2241 glpA P123L - x - - - - 
b2332 yfcO G183D - - - - x - 
b2368 emrK A202V - - - - x - 
b2464 talA G138E - - - - x - 
b2479 gcvR D38N - - - - x - 
b2482 hyfB R380Q - - - - x - 
b2491 hyfR A285T - - - - x - 
b2493 yfgO A154V - - - - x - 
b2538 hcaE G318D - - - - x - 
b2574 nadB V41I - - - x - - 
b2599 pheA* D18N - - - - x - 
b2600 tyrA* G90E - x - - - - 
b2642 yfjW T227I - - x - - - 
b2661 gabD G459D - - - - x - 
b2677 proV A194T - - - - x - 
b2678 proW R181H - - - - x - 
b2681 ygaY A131T - - - - x - 
b2698 recX W161* - x - - - - 
b2703 srlE G73D - - - - x - 
b2705 srlD D209N - - - - x - 
b2710 norV D73N - - - - x - 
b2710 norV W119* - - - - x - 
b2730 hypE G241D - - - - x - 
b2750 cysC A153V - - - - x - 
b2764 cysJ A194V - - - - x - 
b2764 cysJ T25M - - - - x - 
b2764 cysJ P6S - - - - x - 
b2766 ygcN E277K - - - - x - 
b2775 yqcE G328E - - - - x - 
b2784 relA P253S - - - - x - 
b2784 relA A247V - - - - x - 
b2785 rlmD T241I - - - - x - 
b2786 barA V375I - - - - x - 
b2786 barA P797S - x - - - - 
b2803 fucK A412V - - - - - x 
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Gene Gene 
name 
Mutein Parental 
strain 
Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
b2810 csdA A198V - x - - - - 
b2822 recC D906N - x - - - - 
b2834 tas T342I - - - - x - 
b2835 lplT R395H - - - - x - 
b2838 lysA E202K - x - - - - 
b2873 hyuA A46V - x - - - - 
b2874 yqeA V184M - - - - x - 
b2879 ssnA D207N - - - - x - 
b2882 xanQ D466N - - - - x - 
b2933 cmtA G109E - - - - x - 
b2938 speA V365M - - - - x - 
b2942 metK T44I - - - - x - 
b2943 galP Q147* - - - - x - 
b2955 yggW A377V - - - - x - 
b2976 glcB E630K - - - - x - 
b2979 glcD E288K - - - - x - 
b2981 yghO W22* - x - - - - 
b2983 yghQ A321T - - - - x - 
b2988 gss W305* - x - - - - 
b2988 gss E37K - x - - - - 
b2993 hybD T87I - - - - x - 
b2995 hybB G235S - x - - - - 
b2996 hybA S122F - - - - x - 
b2996 hybA D43N - x - - - - 
b2997 hybO P220S - - - - x - 
b3006 exbB V237I - x - - - - 
b3008 metC A91V - x - - - - 
b3009 yghB G129E - - - - x - 
b3013 yqhG S195F - x - - - - 
b3017 ftsP A158V - x - - - - 
b3019 parC G53S - x - - - - 
b3020 ygiS W84* - x - - - - 
b3020 ygiS V76M - x - - - - 
b3046 yqiG A573V - x - - - - 
b3046 yqiG G1191D - - - - x - 
b3049 glgS T34I - - - - x - 
b3051 yqiK V53I - - - - x - 
b3051 yqiK G176D - - - - x - 
b3056 cca G16E - x - - - - 
b3056 cca G149D - x - - - - 
b3067 rpoD D193N - - x - - - 
b3093 exuT Q431* - - - - x - 
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Gene Gene 
name 
Mutein Parental 
strain 
Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
b3095 yqjA A143V - - - - x - 
b3102 yqjG R275C - - - - x - 
b3104 yhaI P49L - - - - x - 
b3110 yhaO G183D - - - - x - 
b3114 tdcE R67H - - - - x - 
b3124 garK S343N - - - - x - 
b3124 garK A51V - - - - x - 
b3128 garD E71K - - - - x - 
b3142 yraH G11S - - - - x - 
b3142 yraH G18D - - - - x - 
b3151 yraQ A9T - - - - x - 
b3158 yhbU L13F - - - - x - 
b3160 yhbW A220V - - - - x - 
b3161 mtr* D317N - - - - x - 
b3162 deaD G459D - - - - x - 
b3162 deaD V208M - - - - x - 
b3163 nlpI E290K - - - - x - 
b3163 nlpI A155T - - - - x - 
b3164 pnp E646K - - - - x - 
b3165 rpsO D74N - - - - x - 
b3168 infB T344I - - - - x - 
b3178 ftsH V86I - - - - x - 
b3182 dacB W153* - - - - x - 
b3194 mlaE T227M - - - - x - 
b3225 nanA P182L - - x - - - 
b3482 rhsB R772K - - - - x - 
b3591 selA A373T - - - - x - 
b3638 yicR G82E - - - - x - 
b3671 ilvB D126N - - -x - - - 
b3725 pstB L177F - - - - - x 
b3744 asnA E244K - - - - - x 
b3745 viaA S397N - - - x - - 
b3971 rrfB P24S - - - - x - 
b4239 treC A344T - - - - x - 
b4241 treR R117C - - - - x - 
b4279 yjhB R63K - - - - x - 
b4295 yjhU M156I - - - - x - 
b4296 yjhF W427* - - - - x - 
b4301 sgcE G171R - - - - x - 
b4305 sgcX D193N - - - - x - 
b4305 sgcX G90D - - - - x - 
b4308 yjhR T373I - - - - x - 
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Gene Gene 
name 
Mutein Parental 
strain 
Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
b4312 fimB T177I - - - - x - 
b4319 fimG S55F - - - - x - 
b4320 fimH S93F - - - - x - 
b4324 uxuR P26S - - - - x - 
b4325 yjiC A248T - - - - x - 
b4326 iraD P78S - - - - x - 
b4332 yjiJ A160T - - - - x - 
b4356 lgoT A287V - x - - - - 
b4379 yjjW P239S - x - - - - 
b4392 slt V51M - x - - - - 
b4393 trpR* G85E - x - - - - 
b4423 ldrC S29G - - - - x - 
b4462 ygaQ T598I - x - - - - 
b4463 ygcU L432F - - - - x - 
b4466 sslE G1484S - - - - x - 
b4466 sslE D619N - - - - x - 
b4466 sslE R146C - - - - x - 
b4467 glcF V156M - - - - x - 
b4467 glcF D96N - - - - x - 
b4492 ydbA E52K - - x - - - 
b4492 ydbA S641N - - x - - - 
b4498 gatR L576F - - - - - x 
b4498 gatR P83L - - - - - x 
b4537 yecJ T77I - - - - - x 
b4565 sgcB C47Y - - - - x - 
b4582 yoeA G302S - - - - - x 
b4639 yeeH S20N - - x - - - 
b4661 yfcU D603N - x - - - - 
b4696 yneO A1023T - - x - - - 
 
Table S4.2.1.2: Summary of identified amino acid exchanges or stop codons (stop) in isolated 
clones by the mtr biosensor-based FACS HT screening of an E. coli K-12 MG1655 library 
mutagenized by MNNG. 
Amino acid Exchanged to... Amount  Amino acid Exchanged to... Amount 
Alanine Threonine 27  Glutamine Stop 3 
Alanine Valine 32  Arginine Cysteine 9 
Cysteine Tyrosine 2  Arginine Tryptophan 2 
Aspartate Asparagine 25  Arginine Histidine 7 
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Amino acid Exchanged to... Amount  Amino acid Exchanged to... Amount 
Aspartate Glycine 1  Arginine Glutamine 1 
Glutamate Lysine 18  Arginine Lysine 2 
Glycine Aspartate 32  Serine Leucine 2 
Glycine Glutamate 13  Serine Phenylalanine 6 
Glycine Serine 9  Serine Asparagine 7 
Glycine Arginine 5  Serine Glycine 1 
Histidine Tyrosine 1  Threonine Methionine 2 
Histidine Arginine 1  Threonine Isoleucine 19 
Leucine Phenylalanine 7  Threonine Serine 1 
Methionine Isoleucine 2  Valine Methionine 9 
Proline Leucine 10  Valine Isoleucine 13 
Proline Serine 27  Tryptophan Stop 10 
 
Supporting Figures 
 
Fig. S4.2.2.1 The development of the biomass-specific L-leucine and L-alanine production 
during biosensor-driven adaptive laboratory evolution of the growth-coupled L-leucine 
production strain C. glutamicum MV-Leu7. The MV-Leu7 strain containing the plasmid-encoded 
Lrp biosensor was cultivated in CGXII minimal medium until reaching an OD600 of 4. 
Subsequently, the cells with the top 10% fluorescent output were isolated by FACS and re-
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cultivated. The procedure of iterative sorting and re-cultivation was modified from Mahr et al. 
(2015).  
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